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How the single cell of the fertilised egg becomes the wide variety of cell types present in 
mammals, for example nerve cells, gut cells and skin cells, while still possessing the same 
blueprint for construction of components (DNA) is a central question in biology.  If all cells 
have the same blueprint, why don’t they all make the same components? The difference 
between cell types is routed in differences in how they utilise DNA. In the last 50 years it has 
become apparent that the scaffolding that DNA interacts with is essential in deciding how it 
is utilised. In my project, I seek to work out the function of a cell component (LSH) that alters 
the arrangement of that scaffold, allowing machinery of the cell greater or lesser access to 
certain parts of the DNA blueprint and altering how much certain components are made by 
the cell. To do this I use a genetically modified mouse that can remove LSH and replace it at 
different points in the animal’s life. By doing this I have been able to show that LSH in early 
life is essential to produce insulating cells that wrap around nerve cells and allow them to act 
as efficient electrical circuits controlling movement. These same insulating cells are 
destroyed in diseases such as multiple sclerosis, causing patients to lose control of 
movement to varying extents. For some patients, the disease is made more severe as they 
are not able to produce more insulating cells after the initial ones are destroyed. 
Understanding why my genetically engineered mice are unable to produce insulating cells, 
and how alterations in the DNA scaffold cause this problem, could therefor provide insights 




Previous work in embryonic cell lines has implicated LSH in the deposition of DNA 
methylation, a key regulatory epigenetic modification during mammalian development. We 
have generated a conditionally reversible knock-out of Lsh (Lshoff) to investigate its role in 
vivo. Lshoff/off mice survive to adulthood but develop a tremor and ataxia phenotype. 
Transmission election microscopy of nervous tissue shows this phenotype is concurrent with 
central nervous system (CNS) hypomyelination. Lshoff/off animals also have a reduction in 
mature oligodendrocyte (mOL) cell numbers, but similar number of oligodendrocyte (OL) 
lineage cells in total, indicating the presence of an OL differentiation defect. Conversion to 
Lshon/on in OPCs leads to complete rescue of the phenotype, suggesting LSH expression in 
the OL lineage is necessary for terminal differentiation. OPC specific knock-out of Lsh 
however produces no phenotype. Sequencing of Lshoff/off adult optic nerve RNA reveals 
under-expression of genes associated with mOLs, the myelinating cells of the CNS, but no 
cognate upregulation of oligodendrocyte precursor cell (OPC) markers.  Interrogation of DNA 
methylation in rescued OPCs however reveals scant to no rescue in the hypomethylation 
present in Lshoff/off OPCs. Taken together these results show an essential role for LSH in OL 
differentiation and that LSH dependent DNA methylation patterns are not required prior to 
differentiation to mOLs. We hypothesize that early life LSH expression instead establishes a 
DNA methylation independent chromatin state required for differentiation and this is 





1. Introduction- Chapter One 
Large eukaryotic genomes present cells with the requirement to compact their DNA 
compliment within a nucleus of limited size. An additional requirement, for organisms that 
produce specialised cell types, is to utilise their identical genomes in different ways to 
produce these cell types. Both of these requirements have long been proposed to be met by 
spatial organisation, protein interaction with, and chemical modification of DNA in chromatin, 
the large nucleoprotein complex in which the genome of eukaryotic cells is contained 
(Kornberg 1974, Holliday and Pugh 1975, Stedman and Stedman 1950). 
1.1 Chromatin and Genome Function 
The fundamental repeating component of chromatin comprises of ∼147bp of DNA wrapped 
around two copies of each core histone protein variant H2A, H2B, H3 and H4, termed the 
core nucleosome (Luger et al. 1997, Richmond and Davey 2003, Kornberg 1974). These 
nucleosomes exhibit non-random spacing across DNA in both yeast and metazoans, leading 
to consistent amounts of DNA exposed between consecutive wrapping nucleosomes at 
certain loci in cells (Schones et al. 2008, Mavrich et al. 2008, Lee et al. 2007). The 
composition of histone variants within nucleosomes and their N-terminal tail post-
translational modifications (PTMs) are distributed unevenly across the genome (Kundaje et 
al. 2012, Chen and Dent 2014, Pokholok et al. 2005).  
A non-nucleosomal aspect of chromatin is the covalent attachment of a methyl group to the 
carbon five of cytosine or DNA methylation. This also has a non-even distribution in the 
genome. In vertebrates, DNA methylation is most prevalent in a CpG sequence context, 
though it can occur in different contexts at a frequency dependent on cell-type (Gautier et al. 
1977, Ramsahoye et al. 2000). The extent of CpG methylation preference is such that the 
genome is relatively depleted of CpG dinucleotides due to the frequent spontaneous 
deamination of 5’methyl-cytosines into thymidines across evolution (Bird 1980, Coulondre et 
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al. 1978). However, at particular regions, termed CpG islands (CGIs), this CpG methylation 
bias is reversed (Bird et al. 1985).  
The non-random spacing of all these chromatin components has led to them being subject to 
investigation hypothesising a potential function.Historically however, evidence for a 
functional role of chromatin appeared long before the molecular characterisation. Chromatin 
can be classified on a cytogenetic basis into heterochromatin and euchromatin (Heitz 1928). 
Early work in Drosophila found that few phenotypes of mutation mapped genetically to 
deeply staining heterochromatic regions of chromosomes (Weiler and Wakimoto 1995). This 
has been found to correspond to a lack of protein coding genes by subsequent sequencing 
and annotation of the Drosophila genome (Smith et al. 2007). In addition, observations that 
chromosomal rearrangements positioning euchromatic genes proximal to heterochromatic 
loci led to mosaic inactivation of gene expression within tissues, a phenomenon termed 
position effect variegation (PEV), hinted at a functional role for heterochromatin in gene 
silencing (Muller 1930). In the many years since these initial observations, there has been 
much work into the molecular mechanisms of chromatin’s association with gene activity and 
this has been enabled by increased understanding of the components of repressive and 
active chromatin at the DNA and protein level. In order to provide context for the work 
carried out in this thesis, I will give a brief overview of some of this work in this introduction. 
1.1.1 Histone PTMs 
Genetic screens defining factors modulating PEV uncovered a variety of enzymes and 
structural DNA binding proteins (Wallrath 1998). These include histone methyltransferase 
and deacetylase enzymes which catalyse, for example, trimethylation of histone 3 lysine 9 
(H3K9me3) and removal of histone acetylation, along with a variety of other PTMs (De 
Rubertis et al. 1996, Rea et al. 2000, Jenuwein and Allis 2001). These PTMs are often 
conserved across evolution, indicating functional relevance. Chromatin immunoprecipitation 
experiments (ChIP) using antibodies specific to histone PTMs enables purification of the 
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DNA associated with specifically modified nucleosomes. Using this technique for 
interrogation of the PTMs at both specific loci and genome wide reveal an evolutionarily 
conserved correlation between presence of certain PTMs at a locus, such as a promoter or 
enhancer regions, and transcriptional state of the associated gene (Noma et al. 2001, 
Heintzman et al. 2007, Boyer et al. 2006). This has enabled association of certain histone 
PTMs to poorly transcribed regions, such as H3K9me3 and histone 3 lysine 27 trimethylation 
(H3K27me3) and to more well transcribed regions, such as histone 3 lysine 4 tri-methylation 
(H3K4me3), histone 3 acetylation and, in gene bodies, histone 3 lysine 36 tri-methylation 
(H3K36me3) (Allis and Jenuwein 2016).  Further work has also characterised how the 
presence of certain modifications excludes or enables associated binding of proteins 
essential for transcriptional activation, depending on precise context (Xin and Rohs 2018).  
1.1.2 Nucleosome Positioning 
The correlation between chromatin state and transcriptional activity is also apparent at the 
level of nucleosome positioning. The promoters of active genes are characterized by a 
nucleosome-depleted region (NDR), flanked by a downstream nucleosome a canonical 
distance from the transcription start site (TSS), termed the +1 nucleosome followed by 
nucleosomes arrayed with gradually decreasing regularity of spacing within a population 
further downstream from the locus (Pokholok et al. 2005, Barski et al. 2007). Generally there 
is an inverse correlation between nucleosome occupancy in promoter regions and gene 
expression and a positive correlation between stringency of phasing and +1 nucleosome 
positioning relative to the TSS and expression (Weiner et al. 2010, Chereji et al. 2016, 
Schones et al. 2008). In vitro transcription assays on reconstituted chromatin reveal the 
precise position of the +1 nucleosome is required for efficient transcription and recruitment of 
transcriptional activators (Stunkel et al. 1997, Zhao et al. 2001). However, this is dependent 
on the histone composition of the +1 nucleosome, with in vivo studies in yeast suggesting 
the  creation of a barrier to RNA polymerase II translocation in yeast, the effectiveness of 
which varies depending on subnucleosomal content (Weber et al. 2014). The effect this 
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nucleosome patterning on transcription is thought to mediated by alteration in accessibility of 
DNA and thus its ability to act as an enzyme substrate. 
1.1.3 DNA Methylation 
DNA methylation has also long been associated with gene silencing. This originates from the 
observation that it precludes binding of certain restriction enzymes to DNA, and thus could 
potentially alter other protein interactions with the DNA substrate (Mann and Smith 1977, 
Holliday and Pugh 1975). Approximately 60% of annotated gene promoters contain CpG 
islands, hinting again at a functional relevance for these unmethylated regions (Antequera 
and Bird 1993, Larsen et al. 1992, Saxonov et al. 2006). More recently, an ability to 
interrogate DNA methylation and histone PTMs genome wide has revealed correlation 
between the presence of DNA methylation at certain regions and heterochromatin (Meissner 
et al. 2008). Further evidence for DNA methylation’s role as a repressive chromatin mark 
comes from observation that treatment with 5-aza-2’deoxycytodine, an inhibitor of DNA 
methyltransferase enzymes, leads inhibition of cellular differentiation as well as large scale 
depression of genes (Jones and Taylor 1980, Yang et al. 2012). However, the relationship 
between DNA-methylation and gene expression is far from simplistic. For example, 
promoters associated with CGIs remain largely unmethylated despite expression status 
altering during development and when silenced are more typically marked with H3K27me3 
(Brinkman et al. 2012). With the presence of DNA methylation at the flanks of CGIs being 
posited to be important for prevention of spreading of the repressive H3K27me3 to proximal 
regions (Lindroth et al. 2008) (Brinkman et al. 2012). For a subset of promoters, reduction in 
gene expression following developmental transitions is co-occurrent on CpG methylation 
(Epsztejn-Litman et al. 2008). Locus specific interrogation of the Oct4 gene promoter show 
that H3K9 methylation precedes DNA methylation establishment during in vitro differentiation 
of mouse embryonic stem cells and that both the histone methyltransferase G9a and de 
novo DNA methyltransferases DNMT3a and 3b are required for stable silencing of the Oct4 
expression during differentiation (Feldman et al. 2006). Cells with genetic ablation of the 
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catalytic SET domain of G9a can still deposit DNA methylation at G9a dependent promoters 
and  these promoters are still marked by H3K9me3 (Dong et al. 2008), making the cause 
consequence relationship between histone PTMs and DNA methylation unclear. DNA 
methylation has also been associated with the silencing of transcriptional features with 
reduced CpG density regulatory regions. These features are often found in more repetitive 
genomic regions. Pericentromeric repeats comprise of major and minor satellite sequences 
which extend from centromeres of chromosomes in tens of thousands of tandem repeats 
(Lehnertz et al. 2003). Silencing of these regions is essential for normal development and 
requires DNA methylation, with missense mutations in the DNA methyltransferase gene 
Dnmt3b causing immunodeficiency, centromeric instability and facial abnormality (ICF) 
syndrome (Xu et al. 1999). Deposition of H3K9me3 at these regions, while upstream of DNA 
methylation, is also insufficient for stable silencing (Lehnertz et al. 2003).  
Transposable elements also require DNA methylation for silencing. These elements 
comprise around 40% of mammalian genomes and can be classified into 3 major classes 
long interspersed nuclear elements (LINEs), short interspersed nuclear elements (SINEs) 
and long terminal repeat retrotransposons (LTRs) (Waterston et al. 2002). Full-length LTRs, 
intracisternal A particle (IAP) retroviruses, which are controlled by LTR promoters, and 
LINEs, require promoter hypermethylation to remain transcriptionally silent,(Yoder et al. 
1997) (Walsh et al. 1998, Liang et al. 2002). Again, this silencing via DNA methylation 
occurs downstream of H3K9me3 establishment at promoters but is required for stable 
silencing despite the presence of H3K9me3 at a subset, but not all elements (Karimi et al. 
2011).  
DNA methylation’s function is also highly divergent depending on the precise genomic 
feature it resides in. Gene bodies for example, often display high levels of DNA methylation, 
within highly transcribed regions, which has been hypothesised to function in preventing 
aberrant transcription initiation within the gene body or aid in mRNA splicing (Laurent et al. 
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2010). Analysis of differential expression in RNA-sequencing of Dnmt3b (DNA methyl 
transferase 3B) knock-out in embryonic stem cells has linked reduction in specifically gene 
body methylation to aberrant transcription initiation (Neri et al. 2017). The role for gene body 
methylation in transcription initiation site specification and mRNA splicing has also been 
evidenced by transcriptional and chromatin state profiling of B-cells derived from ICF 
patients mutated for DNMT3B (Gatto et al. 2017).  
Recently, a role for DNA methylation in the regulation of enhancer activity has been 
evidenced through studies into the function of TET enzymes, which facilitate the removal of 
5mC by catalysing conversion to the intermediate 5’-hydroxymethyl cytosine (Hon et al. 
2014, Wang et al. 2018). This in conjunction with studies looking at lineage specific 
enhancer activation during cell differentiation transitions add another layer of complexity to 
DNA methylation’s correlation with transcription (Rasmussen et al. 2015). 
1.1.4 Chromatin State 
As hinted in the previous section, there is often associations and crosstalk between patterns 
in nucleosome spacing, variant composition, histone PTMs and DNA methylation. It is useful 
therefor to define the combinations of components that often co-occur (such as repressive 
histone PTMs and DNA methylation) into “chromatin states” on the basis of what functions 
they are associated with in the genome (Allis and Jenuwein 2016). Although correlation is 
apparent across multiple domains of life, unravelling the causative relationship between 
chromatin state and gene expression however factors has proven difficult. 
One aspect required for a causative role of chromatin state in transcriptional output is the 
correlation between them remaining in response to change. Indeed, following stimuli that 
lead to changes in cell-lineage commitment, chromatin state alters in conjunction with 
change in transcriptional output (Mikkelsen et al. 2007). This is also observable through 
changes in nucleosome positioning at TSSs in response to cellular stimuli that alter 
transcription (Shivaswamy et al. 2008). Further to this, profiling of chromatin state at distinct 
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stages in lineage progression also shows changes in chromatin state at certain regulatory 
elements prior to transcriptional upregulation (Lara-Astiaso et al. 2014). In addition, targeting 
of chromatin remodelling proteins, that shift nucleosomes relative to each other, to specific 
genomic loci, causes an increased nucleosome density and results in decreased 
transcription of associated genes (McKnight et al. 2016). Further evidence for a causal 
relationship at some loci can be found by similar targeting experiments using enzymes that 
catalysed DNA methylation (Maeder et al. 2013, Vojta et al. 2016, Amabile et al. 2016, Liu et 
al. 2016, Stepper et al. 2017). There are examples to the contrary however, with changes in 
expression occurring prior to chromatin state change (Scruggs et al. 2015, Cirillo et al. 2002, 
Hsu et al. 2015) or gene expression not being impacted by change in chromatin state 
(Maeder et al. 2013, Lea et al. 2018). 
Taken together, the overview of the chromatin biology presented here supports the notion 
that transcriptional output of the cell is dynamically regulated by and can be reinforced 
following modification at the level of histone PTMs, DNA methylation and nucleosome 
position. Study of this effect complicated by impact transcription itself has on chromatin 
state, and there is evidence for both chromatin state changes being a cause and a 
consequence of change in transcription, depending on the precise context. 
1.2 Chromatin Remodelling ATPases 
Not discussed in any depth in the previous sections is the effects of chromatin state are 
thought to be mediated at the level of protein recruitment to functional genomic features 
either through interaction between chromatin “readers” with their associated marks, or 
increased access of enzymes to their DNA substrate (Musselman et al. 2012). In addition, 
chromatin modifying enzymes such as those which catalyse histone PTMs or DNA 
methylation, require accessibility to their substrates for chromatin state to change. Enzymes 
that can influence the accessibility of chromatin are therefore essential in enabling chromatin 
to perform its dynamic function. 
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Enzymes that alter nucleosome position relative to DNA, dependent on ATP hydrolysis, are 
termed ATP dependent chromatin remodellers. Recognition of the broad spectrum of 
chromatin remodellers present in cells came from inference of function through phylogenetic 
characterisation.  As more protein sequences became available through the advent of 
widespread molecular cloning, a large group of proteins sharing a common set of sequence 
motifs present in the Escherichia coli helicases rep, uvrD, recB and recD was identified 
(Gorbalenya et al. 1988, Gorbalenya and Koonin 1993).  Within the sf2 superfamily of this 
helicase motif group, further families were defined based on helicase motif composition, one 
such family contains the yeast transcriptional activator SNF2 (Bork and Koonin 1993). SNF2 
was first linked to chromatin modifying activity by suppressor screens identifying histone 
protein mutations were capable of alleviating SNF2 mutation phenotypes (Hirschhorn et al. 
1992). It was later demonstrated in vitro that the products of SNF and the closely related 
SWI genes formed a complex with a number of other protein subunits, capable of moving 
nucleosomes relative to each other (Côté et al. 1994, Kwon et al. 1994). Subsequently 
multiple other such complexes were isolated and characterised containing unique subunit 
compositions and distinct ATPases (Tsukiyama and Wu 1995, Tran et al. 2000, Shen et al. 
2000). 
Early phylogenetic analysis based on sequence identity between the conserved ATPase 
domains of sf2 family members placed chromatin remodellers into 4 distinct sub–families 
that also contain common domains outside the core ATPase (Eisen et al. 1995). However, 
following rapid expansion of sequencing data available at the beginning of the 21st century, 
new analysis revealed many genes, despite having ATPase similarity, do not fit all the 
classical features of the previously defined subfamilies, especially outside of the core 
ATPase domain (Flaus et al. 2006). One such family is that of LSH (Lymphoid Specific 
Helicase), a name which describes the origin tissue for initial isolation and domain exploited 
for isolation, rather than an accurate description of its expression pattern or function, is the 
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mouse homologue of the plant chromatin remodeller DDM1 (Jarvis et al. 1996)(Deficient in 
DNA Methylation 1) (Brzeski and Jerzmanowski 2003).  
Well studied chromatin remodeller sub-families, including those originally distinguished 
phylogenetically (SWI/SNF, ISW1, CHD and INO80) have been functionally stereotyped in 
the ways they often manipulate their nucleosome substrate, though there is a wide range of 
diversity in function within subtypes, and no one subtype is exclusively linked to a function.  
1.2.1 SWI/SNF Chromatin Remodellers 
LSH is most closely related to the SWI/SNF subfamily on the basis of routed comparison of 
helicase domain similarity (Flaus et al. 2006). The core ATPase containing subunit of this 
class of remodelling complex is structurally defined by two RecA like lobes flanking a 
helicase domain that binds actin related proteins with subfamily members also containing a 
bromodomain at the C-terminal (Eisen et al. 1995, Schubert et al. 2013). SWI/SNF 
complexes in mammals and other higher eukaryotes are various, with subunit and core 
ATPase containing composition often unique to different developmental contexts. For 
example, mice have an embryonic specific complex conformation of the BRG1 core ATPase 
subunit containing BAF complex (esBAF) that is required for maintaining pluripotency genes 
expression (Ho et al. 2009). By contrast when cells differentiate to neurones this complex 
switches from npBAF, expressed in neural progenitor cells (NPCs) to nBAF on 
differentiation, which has characterised roles in dendritic outgrowth, neuronal cell fate 
determination and cell cycle exit (Wu et al. 2007, Lessard et al. 2007).  
This subunit composition complexity also leads to an increase in functional complexity in 
higher eukaryotes. Yeast SWI/SNF containing remodelling complexes are well characterised 
to be recruited by transcription factors (TFs) to promoters and then remodel nucleosomes to 
allow access to the underlying DNA (Burns and Peterson 1997, Cosma et al. 1999). 
However in mammalian T-cell differentiation, the BAF complex is capable of modulating long 
range interactions between regulatory elements of the lineage specific Cd4 gene, and either 
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promotes activation or repression depending on developmental stage (Wan et al. 2009, Chi 
et al. 2003, Chi et al. 2002). Despite this increased functional flexibility in mammals, 
conserved functions in gene regulation through regulation of access, either facilitating or 
preventing, SWI/SNF modellers can be stereotyped as controllers of chromatin access to 
accessory factors (Clapier et al. 2017).  
1.2.2 The Chromatin Remodelling ATPase LSH 
Based on this homology to SWI/SNF, it could be speculated that LSH may have a similar 
role in regulating DNA accessibility. However, early characterisation linking LSH-subfamily 
proteins to a role in genomic CpG methylation hints at a more complex mechanism of action 
for the proteins than alteration of accessibility to transcription factors.  
The gene for the plant homologue of LSH, DDM1 was identified in two independent genetic 
screens for mutations that alter DNA methylation and heterochromatin in plants (Vongs et al. 
1993, Mittelsten Scheid et al. 1998). This effect on DNA methylation was also shown to be 
independent of metabolite levels by experiments showing unaltered levels of the important 
substrate donor required for DNA methylation, S-adenosylmethionine (SAM) (Kakutani et al. 
1995). DDM1 was also identified as a chromatin remodelling protein by sequence homology 
following its cloning, with all DNA methylation impacting mutations found to be present in or 
deleting through frameshift the ATPase domain, indicating remodelling activity essential for 
DNA methylation (Jeddeloh et al. 1999). DDM1 remodelling activity has subsequently been 
demonstrated in vitro (Brzeski and Jerzmanowski 2003). And it’s physiological importance 
demonstrated with characterisation of mutant phenotypes revealing morphological 
abnormalities, including defects in leaf structure, flowering time, and flower structure 
(Kakutani et al. 1996). 
A human homologue for LSH/DDM1 was cloned (Geiman et al. 1998) and genetic 
perturbation of mammalian LSH revealed similar functional properties to DDM1, though with 
a supposedly more severe developmental phenotype. Initial homologous recombination 
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mediated knock-out in mouse (hereby termed Lsh-/-), deleting exons 6-7 of the gene and 
abolishing full-length protein expression causes perinatal lethality, but otherwise grossly 
normal embryonic development (Geiman et al. 2001). Lsh-/- embryos also lack genome wide 
DNA methylation (Dennis et al. 2001). Other studies which generated hypomorphic 
mutations to LSH via removal of the ATPase domain also reveal genome wide 
hypomethylation, with mice surviving postnatally, albeit with a severe growth retardation 
phenotype (Sun et al. 2004). DNA methylation deficit in Lsh-/- is localised to various repetitive 
sequences, including major and minor satellite repeats and large chromosomal domains 
associated with the nuclear lamina (Muegge 2005) (Yu et al. 2014). 
The DNA methylation loss in the absence of LSH is associated with over expression of 
developmentally regulated genes in mouse embryonic fibroblasts derived from Lsh-/- 
embryos and renewed silencing of these elements requires the G9a histone methyl 
transferase, much like previously discussed DNA methylation related silencing (Myant et al. 
2011). The cell autonomous role for LSH in this genome wide DNA methylation was 
underlined in studies rescuing expression in MEFs using lenti-viral transduction, crucially 
demonstrating that LSH’s capacity to induce de novo methylation is not dependent on the 
extrinsic factors and signalling that occur during the developmental stage at which DNA 
methylation is normally established, and so could be important in subsequent somatic cell 
differentiation (Termanis et al. 2016, Smith et al. 2012). The extensive subcloning required 
for purification of MEF lines rescued for LSH in this experiment does not allow for 
interrogation of the sequence of events required for LSH mediated methylation. It also 
doesn’t address whether under physiological conditions, methylation or silencing would be 
restored in somatic cells that have had LSH expression rescued. 
It has been postulated that LSH allows methylation of certain inaccessible regions of 
chromatin via remodelling to allow access of these regions to DNA methyltransferases 
(Meehan et al. 2001). Supporting this hypothesis, LSH interacts with the de novo methyl 
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transferase DNMT3B and histone deacetylases HDACs 1 and 2 (Myant and Stancheva 
2008). This idea has also received support from recent studies that integrated chromatin 
state profiling in DDM1 and Lsh mutants (Lyons and Zilberman 2017). Importantly, LSH’s 
remodelling activity has also been demonstrated in vitro only when interacting with the 
protein CDCA7 (Jenness et al. 2018). Recent identification of mutations in both HELLS 
(human LSH coding gene) and CDCA7 in the previously mentioned ICF syndrome (Thijssen 
et al. 2016). This study confirms the functional relevance of LSH and CDCA7 in human 
disease and development. The postnatal viability of humans with null mutations in HELLs 
also indicates that LSH may not be required for post-natal mammalian development and  
Lsh-/- perinatal lethality may be a specific to mouse, strain genetic background, or an artefact 
of the gene targeting strategy. 
The perinatal lethality of Lsh-/- conceivably supports the conclusion of previous mouse 
knock-out studies for DNA methyltransferase genes that genome-wide hypomethylation of 
DNA is incompatible with development (Walsh and Bestor 1999, Li et al. 1992, Okano et al. 
1999). The apparent progression of Lsh-/- mice beyond the developmental stages of the 
DNMT knock-outs and the ability of similarly hypomethylated Lsh hypomorph mutants to 
survive postnatally, albeit with a debilitating phenotype, suggests the primarily 
heterochromatic regions which LSH is responsible for silencing may not be as deleterious to 
normal development as all regions dependent on the DNMTs.  
Dnmt1 knock-out leads to rapid global hypomethylation of 90% of CpGs in any dividing cell 
type and thus causes lethality due to upregulation of apoptotic gene expression and X 
chromosome inactivation in all but embryonic stem cells (Jackson-Grusby et al. 2001, 
Panning and Jaenisch 1996, T. Chen et al. 2007, Unterberger et al. 2006). Thus, study of 
the cell type specific, less severe, effects of LSH ablation could provide previously missed 
insights on the effect of more subtle changes in DNA methylation in cellular maintenance 
and differentiation.  
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1.3 The Oligodendrocyte Lineage 
A lineage where LSH may play an unknown role in DNA methylation and wider chromatin 
state transitions is that of the myelinating cells of the central nervous system (CNS), OLs. 
Study of the OL lineage benefits from well characterised physiological function and gene 
expression changes that occur in a relatively well-defined lineage progression (Swiss et al. 
2011). This enables relation of mouse phenotypes to specific stages of this progress through 
histological and gene expression profiling experiments. There are also methods for isolating 
the specific cell types and lineage stages that are required for study of chromatin in gene 
regulation (Ho and Crabtree 2010). 
1.3.1 Myelin Function 
To understand how the OL lineage can be studied, and why it should be, it’s important to 
address the physiological function and features of myelin. The correct physiological function 
of the mammalian nervous system is dependent on the correct formation of a myelinated 
axon. Unmyelinated axon membranes (axolemma) contain diffusely distributed voltage-
gated Na+ and K+ channels, which are capable of propagating electrical impulses or action 
potentials in a continuous manner along the axon (Ritchie 1984).The axolemma of 
myelinated axons is dramatically different to unmyelinated counterparts. Voltage-gated Na+ 
channels concentrate in the nodes of Ranvier, short nonmyelinated areas of approximately 
1µm and are positioned between myelin sheaths along one axon (Salzer 1997),  with K+ 
channels in the juxtaparanode, the axon area adjacent to the node (Poliak and Peles 
2003).The area of depolarization therefore is restricted to the nodes allowing action 
potentials can jump from node to node. This saltatory conduction allows much faster impulse 
propagation compared to an unmyelinated axon of the same calibre(Tasaki 1982). Therefore 
when axons become demylinated and the distinctive clustering of the voltage-gated ion 
channels at the node of Ranvier is lost, there is decrease in nerve conduction and 
neurological impairment (Lappe-Siefke et al. 2003). Indeed, mice lacking myelin due to 
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genetic knock-out of key components present a severe ataxic phenotype (Orian et al. 1994). 
Myelinating OLs also produce trophic factors that promote neuronal survival, such as the 
brain-derived neurotrophic factor (BDNF),  glial cell-derived neurotrophic factor (GDNF) and 
insulin-like growth factor (IGF) (Dougherty et al. 2000, Wilkins et al. 2001, Wilkins et al. 
2003)). In addition, OLs have also been shown to offer metabolic support to neurons 
(Fünfschilling et al. 2012, Lee et al. 2012). 
Interestingly there is also an increased extent of myelination of certain axons following 
exposure to social experience in rodents during development (Makinodan et al. 2012, Mount 
and Monje 2017). Thus, processes that regulate myelination and OPC differentiation are 
conceivably connected to memory and learning. This brief overview of the physiological 
function of myelin, underlines the importance of its study, and sheds light on the possible 
phenotypes that a myelin deficiency may present. 
1.3.2 Oligodendrocyte Differentiation During Development 
OL lineage cells undergo multiple stages of differentiation during development. OPCs are 
specified from neural progenitor cells (NPCs) and subsequently differentiate into immature, 
non-myelinating OLs and finally mature into myelinating OLs (Boulanger and Messier 2014). 
1.3.2.1 Anatomy and Timing 
NPCs of the ventricular neuroepithelium of the embryonic neural tube give rise to neurons, 
astrocytes and oligodendrocytes (Miller 2002, Martinez et al. 2013). The neural tube is 
patterned by concentration gradients of different signalling molecules that define domains 
within it, such as the pre-motor domain (pMN) and the p0-p2 domains, each of which give 
rise to distinct cell types (Briscoe et al. 2000) (Rowitch 2004). Motor neurons and OPCs are 
derived from this pMN, which is demarcated by the expression of the transcription factors 
OLIG1 and OLIG2 (Zhou et al. 2000, Lu et al. 2000). The precise timing of specification and 
cellular origin of OL is however controversial. There are conflicting results as to whether 
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OPCs arise from the same progenitors as motor neurons (MNs), or the lineage is specified 
earlier in development. Studies of in vitro differentiated clonally derived progenitor 
populations showed that NPCs in the SVZ can produce both OPCs and MNs (Kalyani et al. 
1997, Qian et al. 2000) (Menn et al. 2006). The dependency for both MN and OPC lineages 
on OLIG1/2 expression, whereas knock-out of previously expressed bHLH transcription 
factors (TFs) perturbed either glial or neuronal differentiation (Vetter 2001), also hinted 
towards a multipotent progenitor origin (Zhou and Anderson 2002). However, derivation of 
some clonal NPC populations resulted in exclusively glial or neuronal cells arising (Qian et 
al. 1998). Moreover, retroviral transduction experiments tracing cell lineage revealed most 
clonally derived lines in vivo were composed mainly of distinct cell types (Luskin et al. 1993). 
Transplantation experiments of mouse cells into chick embryos showed that embryonic day 
13.5 (E13.5) NPCs do not retain capacity to differentiate into MNs in vivo, whereas earlier 
timepoint (E9.5) progenitors do (Mukouyama et al. 2006). Genetic ablation of Olig1 
expressing cells, including NPCs that go on to make MNs, showed a remaining population of 
OLIG2 expressing cells which persist despite complete ablation of NMs in these mice (Wu et 
al. 2006). This taken together with time-lapse imaging of sequential OPC and MN 
specification in zebrafish (Ravanelli and Appel 2015), strongly supports that while 
progenitors may be multipotent in vitro, in vivo OL lineage specification occurs earlier than 
when OPCs arise. 
None the less, OPCs, defined on the basis of PDGFRα expression arise at approximately 
E12.5 in mice (Nishiyama et al. 2009, Levine et al. 1993, Richardson et al. 2006). Though 
multiple waves of OPC specification occur during normal development at embryonic and 
post-natal timepoints (Kessaris et al. 2006). See Fig1.1-1 for an overview of gene expression 
changes and timing of OL lineage differentiation. Following specification OPCs proliferate 
and migrate to form an evenly dispersed population throughout the grey and white matter in 
the CNS (Rowitch 2004). Close to birth, OPCs begin ceasing to proliferation and differentiate 




Figure 1-1 Progression through the oligodendrocyte lineage throughout developmental timepoints 
Schematic of oligodendrocyte lineage progression at different developmental stages in mouse and gene expression typical to different lineage stages that will be used as marker genes 
in the analysis in chapter 4. Gene expression is based on the evidence discussed in chapter 1.3.2.1 , 1.3.2.2, (Swiss et al. 2011), for Pdgfrα (Li et al. 2017) and QKI7 (Bin et al. 2016). 
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expression declines below detectable levels by LacZ assay at around post-natal day 24 
(Foran and Peterson, 1992). More recent evidence for continued myelination following this 
timepoint and throughout adult life comes from label free fluorescent imaging of myelin itself 
(Hill et al. 2018). However, this study does not postulate that this is the result of continued 
major waves of OL differentiation from OPCs.  A subset of OPCs do indeed remain 
undifferentiated into adult life (Dawson et al. 2003) and continue to proliferate (Nishiyama et 
al. 2002). These adult OPCs act to fill vacant spaces missing in adulthood, using self-
sensing to distribute evenly, and can proliferate in response to injury (Hughes et al. 2013). 
Myelinating OLs continue to emerge from this OPC population throughout development 
(Young et al. 2013). Although this continued differentiation throughout life exists, the 
relatively well characterised timepoints that large amounts of differentiation occur, informs 
developmental timepoints to interrogate in suspected OPC differentiation phenotypes. 
1.3.2.2 Transcription Factor Requirements 
OLIG1 and OLIG2 continue to be expressed in OL lineage cells throughout migration 
through the CNS following differentiation from NPCs and in myelinating OLs (Lu et al. 2002) 
(Zhou et al. 2001). OLIG2 does not work in isolation however, with TFs such as ASCL1, 
OLIG1, NKX2.2,  and SOX10  are also subsequently required for OPC differentiation to 
myelinating OLs(Nakatani et al. 2013) (Xin et al. 2005) (Qi et al. 2001) (Stolt et al. 2002). 
OLIG1 and SOX10 bind synergistically to myelin gene promoters, underling their importance 
in activation of the differentiation program (Li et al. 2007). OLIG2 has been shown to 
regulate SOX10 expression by binding to its U2 enhancer in reporter gene activation assays 
(Küspert et al. 2011). The TF MYRF is expressed exclusively in mOLs, both within the OL 
lineage and other CNS cell types (Cahoy et al. 2008, Emery et al. 2009). MYRF binds 
directly to myelin protein component genes, such as MAG, PLP and MBP, stimulates their 
expression (Bujalka et al. 2013). In addition to positive regulators, factors inhibiting 
differentiation play an important role in preventing improper myelin gene transcription. For 
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example, control of OLIG2 DNA binding is conveyed by the inhibitors of differentiation, ID2 
and ID4, which sequester OLIG2 preventing its activity (Samanta and Kessler 2004). Of 
course, more examples of the TF contribution to OL differentiation exist, with work in recent 
years becoming increasingly focused on dissection of the interaction with these key TFs with 
chromatin. 
1.3.3 Epigenetics in Oligodendrocyte Differentiation 
One feature of chromatin biology is that it provides a conceptual framework as to how 
genetic information contained in cells can be utilised differently between cell types, in a 
manner that is heritable between cell divisions. The field exploring this concept has broadly 
been termed epigenetics, with an epigenetic trait being a stably heritable phenotype resulting 
from changes in a chromosome without alterations in the DNA sequence (Berger et al. 
2009). The evidence for this potential heritability of chromatin state is present at several 
levels among the chromatin state components discussed previously (Bird 2002, Margueron 
and Reinberg 2010). 
Epigenetic mechanisms, including recruitment of HDACs and DNA methylation, are also 
strongly implicated in neuronal lineage differentiation (Hsieh and Gage 2004). Treatment of 
mice with HDAC inhibitors reveals the proteins catalytic functions are essential for an 
efficient remyelination response and resultant remyelination defects correlate with 
perturbation of OPC differentiation to mOLs (Shen et al. 2005). This also provides an 
intriguing explanation for inefficient remyelination observed in ageing mice (Shen et al. 
2008). Use of HDAC1 and HDAC2 conditionally deficient mutants shows that depletion of 
the proteins leads to reduced nuclear localization of β-catenin and repression of OLIG2 
expression (Ye et al. 2009). HDACs are also recruited by the transcriptional repressor and 
OPC expressed protein, HES5, to the Mbp promoter (Liu et al. 2006). However, it’s hard to 
pin down the effects of mutations in proteins that cause such wide-reaching perturbation to 
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both chromatin state and cytosolic protein PTMs, that are specifically required for OL 
differentiation. 
Dynamic changes in chromatin state have also been implicated in OPC differentiation. The 
earlier discussed chromatin remodelling ATPase, BRG1 is suggested to be instrumental in 
the OL differentiation process, with expression increasing following differentiation and the 
conditional knock-out, driven by the early expression Olig1 promoter driven CRE, leading to 
decreased expression of differentiation-associate genes such as Sox10 and Mbp.  This is 
co-occurrent with targeting of BRG1 to promoters by OLIG2, indicated by analysis of 
concordant BRG1 and OLIG2 binding sites by ChIP-seq experiments and 
coimmunoprecipitation of the proteins (Yu et al. 2013). However other recent experiments, 
which used CRE expression under control of  a Cnp promoter to facilitate later differentiation 
stage ablation (as the Cnp promoter is active in immature oligodendrocytes) of BRG1 and 
OLIG2, observed an increase rather than decrease in myelination, complicating the picture 
significantly (Bischof et al. 2015) (Mei et al. 2013). An explanation to reconcile these results 
is the role of BRG1 is early in OPC specification, where it conceivably primes loci for 
activation in later maturation, this priming is heritable following subsequent expansion of 
OPCs, and if absent perturbs their differentiation. Knock-out later in the differentiation 
pathway however does not prevent this early priming, and so it can be inherited somatically 
in the absence of BRG1 and differentiation is unperturbed. Other chromatin remodellers 
have also recently been implicated in OL survival and differentiation. Olig1 driven CRE 
expression to generate conditional knock-out of the chromatin remodeller Chd7  revealed a 
requirement for OL differentiation, and ChIP-seq again showed OLIG2 and BRG1 mediated 
targeting to enhancers of maturation essential genes (He et al. 2016). However, again when 
knocked out at a later stage, using a neonatal tamoxifen induced, Pdgfrα driven, ER-CRE,  
CHD7 showed impact on stage progression from OPCs to more mature OLs once 
differentiation was initiated, but did cause a reduction in mOL numbers due to a reduction 
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due to reduced entry into differentiation from OPCs, independent of a co-occurrent survival 
phenotype (Marie et al. 2018).  
These chromatin remodeller studies have all led to focus on genes that are activated in OL 
differentiation, but also the repression of inhibitors of differentiation has been linked to 
epigenetic regulation. Characterization of repressive chromatin marks through the OL 
lineage progression identified H3K9me3 and not H3K27me3 persisting through to mOLs in 
genes related to neuronal differentiation and this was dependent on the activity of the Ehmt1 
and Ehmt2 genes coding the GLP and G9a histone methyltransferases respectively (Liu et 
al. 2015). In addition, there have been attempts to link DNA methylation patterns to proper 
OL differentiation. Though these convincingly show that de novo DNA methylation is not 
required fpr differentiation from OPCs to mOLs, it sheds no light on the methylation patterns 
required to be established before this transition, beyond showing that Dnmt1 knock-out 
prevents differentiation, which as mentioned previously is easily explainable through knock-




1.4 Aims and Approach 
Due to the earlier discussed unconditional knock-out resulting in early life lethality of Lsh-/- 
and possible residual activity in hypomorphic mutations, the function of LSH in mammalian 
development in vivo, any possible importance in regulation of transcription, and 
developmental transitions remains unclear. To shed light on this and provide a tool more 
suitable for investigating time resolved effects of LSH ablation on methylation and gene 
silencing, Chao Li, a post-doc in the Stancheva lab, produced a conditionally reversible 
knock-out of Lsh. The allele comprises of an inserted stop cassette flanked by successive 
inverted Frt and loxP sites into intron 3 of Lsh gene (Fig. 1.1). The theoretical abolition of 
LSH protein in the Lshoff conformation of the allele and ability to restore expression by 
conversion to Lshon by tissue specific/inducible recombinase induction provides a system to 
investigate the following questions, which will form the aims of my thesis: 
• Is Lshoff/off a complete knock-out of LSH expression? What phenotypic defect(s) 
is/are present in the Lshoff/off mouse? 
I will address the first part of this aim in chapters 3 and 4, using experiments to interrogate 
any residual expression of Lsh at the RNA and protein level in Lshoff/off. I will investigate the 
second part by analysis of mouse growth and survival and by histopathological analysis of 
any affected tissue also in chapters 3 and 4. 
• In what cell type(s) and at what stage in development is LSH required? 
I will address this in chapter 3 by molecular verification of the conditionally reversible nature 





• What is the molecular mechanism of any Lshoff/off phenotype? 
I will address this by looking into changes in expression of genes related to the cellular 
defect uncovered in aim 2 in chapter 6. I will also attempt to dissect the chromatin defects 
present in defective cell types following removal of LSH, starting with interrogation of 





Figure 1-2 Lsh conditionally reversible knock-out allele 
  
Schematic representation of Lsh allele generated previously in the Stancheva lab.  A neomycin resistance 
gene fused to GFP with a 5’ splice acceptor (SA) site and 3’ polyadenylation signal (pA) flanked by FRT and 
F3 sites (purple and turquois triangles respectively), heterotypic targets for FLP recombinase and LoxP and 
Lox511 (pink and orange triangles respectively) heterotypic targets for CRE recombinase. Transcripts 
initiated from Lsh promoter are spliced from exon 3 to SA, causing transcription and translation of neomycin-
GFP fusion gene fused to exons 2 and 3 of LSH. On expression of CRE, the cassette recombines and is 
inverted either on the LoxP or Lox511 sites to the antisense strand .The recombined target site is place 
between the 2 sites which were not targeted initially, these are then targeted by CRE and recombined 
resulting in excision of the initially recombined target site and one of the sites in the second recombination. 
The effect of this is that the allele is locked as Lshon and as such splicing occurs as normal and the protein is 
expressed. This can then be reversed in the same sequence of steps by expressing the FLPo recombinase, 




2. Chapter Two- Materials and Methods 
2.1 Materials 
2.1.1 Animals 
Two Lsh+/off strains of mice were generated by injection of 2 independent E14 (129/Ola) ES 
cell lines, heterozygous for the targeted Lshoff allele, into 2 C57Bl6 blastocysts by the 
Scottish Centre for Regenerative Medicine service unit. Chimeric mice with germline 
mutations were identified by presences of the allele in offspring and Lsh+/off mice were 
subsequently were maintained on a mixed 129/Ola/C57Bl/6 background. The weight of 
homozygous Lshoff/off and heterozygous Lsh+/off littermate controls was monitored and 
recorded weekly. To generate homozygous Lshon/on animals, the Lsh+/off mice were crossed 
with a FLPo transgene expressing strain, C57BL/6-Tg(CAG-Flpo)1Afst/Ieg, which was 
purchased from the European Mouse Mutant Archive. Lsh+/off mice were also crossed into 
strain C57BL/6 x CBA Tg(CAG-cre/Esr1*)5Amc for testing of Cre mediated conversion of the 
allele obtained from the Jackson laboratory. To convert the allele specifically in OPCs Lsh+/off 
and Lshon/on mice were crossed with PDGFR-Cre strain, C57BL/6-Tg(Pdgfra-cre)1Clc/J, 
also obtained from the Jackson laboratory. All animals were housed and bred at the School 
of Biological Sciences animal facility and experimental procedures were conducted in 
compliance with the Home Office Animals (Scientific Procedures) Act 1986 under license 
number PPL60/4538. 
2.1.2 Buffers (alphabetical order) 
NE1: 20 mM Hepes pH 7.0, 10 mM KCl, 1 mM MgCl2, 0.1% (v/v) Triton X-100, 20 % (v/v) 
glycerol. 0.5 mM DTT and complete protease inhibitors (Sigma) were added at time of use. 
NE2: 20 mM Hepes pH 7.0, 420 mM NaCl, 10 mM KCl, 1 mM MgCl2, 0.1 % (v/v) Triton X-
100, 20 % (v/v) glycerol. 0.5 mM DTT and complete protease inhibitors (Sigma) were added 
at time of use.  
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Panning buffer: 5µg/ml Insulin, 0.2% BSA in PBS 
Phosphate buffer (PB) (19 parts 0.2M NaH2PO4, 81 parts 0.2M Na2HPO4, 100 parts H2O, pH 
7.4 Sigma) 
Ponceau S staining solution: 1 % (v/v) glacial acetic acid, 0.5 % (w/v) Ponceau S 
SDS PAGE loading buffer (5): 225 mM Tris-HCl pH 6.8, 50 % glycerol, 5 % SDS, 0.05 % 
bromophenol blue. 250 mM DTT was added at time of use. 
SDS Separating gel: 0.1 % SDS, 0.05 % ammonium persulfate, desired concentration of 
acrylamide and 375 mM Tris pH 8.8 and made up to 10 ml with dH2O.  
SDS Stacking gel: 0.1 % SDS, 0.05 % ammonium persulfate, 4 % Acrylamide, 125 mM Tris 
pH 6.8 and made up to 10 ml with dH2O. Transfer buffer: 25 mM Tris, 250 mM Glycine. 
Tris-EDTA (TE): 10 mM Tris-HCl pH 7.5, 1 mM EDTA pH 8.0 
Quantitative PCR reaction mix: 10 ul SYBR qPCR mix, 0.25 uM primers were added to 2 ul 





All primers were ordered from MWG Eurofins. Lyophilised primers were resuspended in 
dH2O to 100 uM stock concentration and stored at -20 degrees. 
Name  Sequence 
Mbp  F TTCCAAAATCTTTAAGCTGGGAGG 
Mbp R AGAGAGGGTCTGCTCTAACTAGC 
Plp F ACCTATGCCCTGACTGTTGTATG 
Plp R CCATGGGAGAACACCATACATTCT 
Cnp F AGAGCTTCGACACTTTATTTCTGG 
Cnp R CTTGCCATACGATCTCTTCACCA 
Pdgfrα F CATGCAGGAAGGCTACTGTTTAAG 
Pdgfrα R AGTCAAGATGTTTGCTTTCTCAGC 
Id2 F AGCACGTCATCGATTACATCTTGG 
Id2 R ATTCAGATGCCTGCAAGGACAG 
Olig2 F CCGAAAGGTGTGGATGCTTATTAC 
Olig2 R ATGGCCCCAGGGATGATCTAAG 
Hes1 F CCAAAAATAAAATTCTCTGGGGACTG 
Hes1 R GCTTTGATGACTTTCTGTGCTC 
Cspg4 F GGAGGATCATTCTCAAGATGGGAG 
Cspg4 R ATTAACAGGAAGGATGGTGATCGT 
Gapdh F GGCTCATGACCACAGTCCATGCC 
Gapdh R CACGGAAGGCCATGCCAGTGAG 
Mag F GGGGCACCTGATAAGTATGAGTC 
Mag R CCAGGTCTGAGTGGGAATAACTG 
Sox10 F TCTGGAGGTTGCTGAACGAAAG 
Sox10 R GTAGTGAGCCTGAATAGCAG 
on off R CTTCAGGCTAAGTCCTTCTAAGTCC 
on F GTATGACATCATCAAGGAAACCCTG 
off F CTTCTAGTTGCCAGCCATCTGTT  
Gfpneo F CGCCGACCACTACCAGCAGAACA 
Gfpneo R GCCGGAGAACCTGCGTGCAATC 
Lsh WT F CCTCCCCAAATAAGCAAATAAAAACT 
Lsh WT R CGAAGGTTGCCAGGTTTTGAGATC 
Cre F GACCGTACACCAAAATTTGCCTGC 
Cre R TTACGTATATCCTGGCAGCGATC 
Flpo F GCACCTGATGACCAGCTTTCTGA 




2.1.4 Antibodies and other affinity reagents 
 
2.1.5 Cell lines 
2.1.5.1 Lsh-/- Mouse embryonic fibroblasts (MEFs)  
Isolated from Lsh-/- embryos derived from crosses of heterozygous animals and immortalised 
by a spontaneous immortalisation (Kathrin Muegge). 
2.1.5.2 Lsh+/+, Lsh+/off and Lshoff/off MEFs 
Isolated from embryos of the appropriate genotype derived from crosses of heterozygous 
Lsh+/off animals, expanded to P3 and frozen (Natalia Torrea). 
2.1.5.3 Lshon/on MEFs 
Isolated from embryos of the appropriate genotype derived from crosses of heterozygous 
Lsh+/on animals, expanded to P3 and frozen (Natalia Torrea). 
Reagent Dilution Application Manufacturer 
Catalogue 
number 














OLIG2 1:1000 IF Merck Millipore AB9610 
Mouse monoclonal anti-
OLIG2 1:200 IF Merck Millipore MABN50 
Goat polyclonal anti-
OLIG2 1:500 IF R&D systems AF2418 
Mouse monoclonal anti-




Rabbit polyclonal to 
anti-NG2 1:500 IF Merck Millipore AB5320 
Rat anti-Mouse CD140a 1:666 OPC Iso. Biolegend 135902 
Anti-BSC1 Griffonia 
Simplicifolia Lectin 
(BSL1) 1:500 OPC Iso. Vector Labs L-1100 
AffiniPure Goat Anti-Rat 
IgG (H+L) 1:333 OPC Iso. Dianova GmbH 112-005-003 
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2.1.5.4 Lsh+/+, Lsh+/off and Lshoff/off Embryonic stem cells (ESCs) 
The original E14 mouse embryonic stem cells (ATTC) (Lsh+/+) generated by either a single 
round (Lsh+/off) of targeting or double round (Lshoff/off) and subsequent clonal selection by 
Chao Li. 
2.1.5.5 Lsh+/off and Lshoff/off OPCs 
Isolated according to methods protocol from P6-P9 brains from mice of the appropriate 
genotype derived from crosses of heterozygous Lsh+/off animals. 
2.2 Methods 
2.2.1 Animal Scoring 
Animals were scored blind weekly according to the following simple scheme: 
 
 
• A score of 4 or more and the animal will be euthanized. 
• A score of 3 and the PIL/PPL holder will be notified and the animals scored daily. 
Weights were taken at the same time as observations for scores. Video examples for 
different levels of Ataxia are included in appendix videos 1-4 
  
Weight Tremor Ataxia 
No loss =0 None =0 None =0  
10% =1  Mild  =1 Mild  =1 
10-20% =3  Moderate =2 Moderate =2 
>20% =4    Severe =3 
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2.2.2 Mammalian Cell Culture  
2.2.2.1 MEFs 
Cultured in DMEM + 10 % Fetal bovine serum (Sigma) and 5ml 100x penicillin streptomycin 
glutamine (PSG)(Gibco) 37⁰C 5% CO2 
2.2.2.2 ESCs:  
Cultured on gelatinized culture flasks (1% in PBS, Sigma) in MEM (Sigma), 10 % FBS, 500µl 
1000x 2- mercaptoethanol, (Gibco) 100x 5 ml sodium pyruvate (Gibco), 5 ml PSG, 5ml non-
essential amino acids (Gibco) and 1:1000 dilution of LIF (Produced in Stancheva Lab, batch 
dependent) at 37⁰C 5% CO2. 
2.2.2.3 OPCs:  
Following primary isolation OPCs were cultured at 37⁰C 10% CO2 in the following medium: 
Media Component Concentration Manufacturer 
DMEM (high glucose 
with Glutamax) 1x 
Invitrogen 
B27 Supplement 50x 1x Invitrogen 
OPC-Sato stock 100x 1x See below. 
PSG 100x 1x Gibco 
N-acetyl cysteine (NAC) 0.3678mM Sigma 
Insulin 5µg/ml Sigma 
Trace Element B  1x Cellgro; Mediatech 
Biotin 4.093nM Sigma 
Forskolin 5nM Sigma 
PDGF-AA 10 ng/ml Peprotech 
NT3 5 ng/ml Peprotech 
 
OPC Sato Component Concentration Manufacturer 
DMEM 1x Invitrogen 
Apo transferin 10mg/ml Sigma 
BSA 1% Sigma 
Progesterone 6.25µg/ml Sigma 
Putrescine 1.6mg/ml Sigma 
Sodium selenite 4µg/ml Sigma 
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Plates or coverslips were coated in 1µg/ml Poly-L-lysine (Sigma) dissolved in PBS, washed 
with ddH2O and left to dry thoroughly before plating of cells. 
2.2.3 gDNA extraction  
Tissue samples (HPLC and OPC DNA) were resuspended in 2 ml TE buffer. Proteinase K 
(Sigma) was added to final concentration of 200 µg/ml and SDS (Sigma) added to a final 
concentration of 1 % overnight at 55⁰C. 100 µg/ml RNAse cocktail (Ambion) was added for 
overnight (HPLC) at 37°C. The salt concentration was subsequently adjusted to 200 mM 
with NaCl. Digested peptides were removed through one phenol:chloroform:isoamyl alcohol 
(Sigma, Merck and Merck respectively) and one chloroform extraction. DNA was precipitated 
in 1 volume isopropanol (Merck) and 1/10- 1/5 volume Sodium Acetate (3 M, pH 5.3 Sigma). 
DNA was pelleted, washed in ethanol and resuspended in a suitable volume of TE buffer or 
water. For isolation of gDNA from ear clippings for genotyping, volume of TE was reduced to 
200µl and others adjusted accordingly, RNase was not used. 
2.2.4 Mouse genotyping PCR (all primers) 
Final concentration in reaction: Primers- each at 0.25pmol/ul, 30mM MgCl2 (Sigma), 1x PCR 
buffer IV (75mM Tris-HCL pH8.8, 20mM (NH4)2SO4, 0.01% tween 20 all produced by 
Sigma), 200uM dNTPs, 2.5U Taq Pol (made in the Stancheva lab), 0.2-2ng/ul gDNA.  
Cycling conditions: 95⁰C 5mins, 95⁰C 30s, 58⁰C 30s, 72⁰C 40s, steps 2-3 x35, 72⁰C 10mins. 
2.2.5 Protein quantification  
Bicinchoninic Acid Protein Assay Kit (Sigma) was used for protein quantification. 0.04 
absorbance units are approximately equivalent to 1ug protein. Quantified protein extracts 
were stored at -80°C. 
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2.2.6 Western Blotting 
Nuclei from MEFs or ESCs was disrupted with Dounce homogeniser in NE1 buffer and 
nuclei were pelleted for 5 min at 3000 rpm at 4⁰C. The nuclei were resuspended in NE2 
buffer, treated with Benzonase (thermo scientific) for 30 min on ice and the NaCl 
concentration adjusted to 500 mM. The nuclei were incubated in this high salt buffer on 
rotating wheel for 45 min and the supernatants containing nuclear proteins were collected 
following centrifugation for 15 min at 13000 rpm at 4⁰C. 40-60µg of each nuclear extract 
were resolved on 8.5% SDS-PAGE gel, transferred to nitrocellulose membrane (BioRad). 
Membranes were then stained with ponceau red for 15mins, before washing off using tap 
water and fixation by a brief wash of 10% acetic acid (Merck) and imaged on a Biorad 
Chemidoc. Membranes were then stripped of poncea by washing in 10x TBS until no dye 
was remaining and then incubated with primary antibodies in TBS buffer with 4% skimmed 
milk, 0.1% Tween for all antibodies used followed by detection with secondary either IR-670 
or IR-800 labelled antibodies (LI-COR). The membranes were scanned on Odyssey scanner 
(LI-COR) and the images collected with Image Studio software.  
2.2.7 High Performance Liquid Chromatography 
HPLC was performed by Dr Bernard Ramsahoye on isolated RNase treated gDNA. Relative 
values for 5mC and 5hmC were then normalised to wild-type samples and experimental 
conditions expressed as a percentage of these. 
2.2.8 Tissue Preparation 
For all electron microscopy (EM) mice of appropriate age, post-natal day 24 (P24) 
considered juvenile and P90 or more adult, were live perfused with 4% paraformaldehyde 
(PFA) (Sigma) 2.5% gluteraldehyde (Agar Scientific) dissolved in 0.1M PB.  Perfusion 
consisted of injection of 0.1ml ketamine (Vetalar), medetomidine (Domitar) solution to cause 
terminal anaesthesia followed by opening of the chest and administration of fixative through 
injection into the left atrium after cutting of the pulmonary vein to relieve pressure. Perfusion 
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was considered complete when the liver appeared cleared of blood and movement in 
extremities had ceased. Spinal cord optic nerve and sciatic nerve tissue was then dissected 
and transferred to post fixative solution consisting of 1% gluteraldehyde in 0.1M PB and 
stored until staining at 4°C. 
For OLIG2 QKI7 staining Lshoff/off and control P14 and P90+ adult mice were perfused as 
described for EM with the exception that the fixation and post-fixative used was 4% PFA 
(Sigma) in phosphate buffered saline (PBS).  Optic nerves and spinal cords were dissected 
and immersed in post-fix for 2 hours at 4°C these were then washed in PBS before 
dehydration by overnight incubation at 4°C in first 15% followed by 30% sucrose (Fisher 
Scientific) in PBS.  
For all other antibody staining tissue was immersed overnight in 4% PFA (PBS) overnight 
these were then washed in PBS before dehydration by overnight incubation at 4°C in first 
15% followed by 30% sucrose (Fisher Scientific) in PBS.  
Tissue was then embedded in OCT (VWR Chemicals) and 10μm sections cut and stored at -
20⁰C until staining.   
2.2.9 Electron Microscopy 
Post-fixed tissue was stained using 1% osmium tetroxide in 0.1M PB, dehydrated using 
graded ethanol series washes, infiltrated with propylene oxide and embedded in TAAB 812 
resin.  Ultrathin sections; 60nm thick were cut from selected areas, stained in Uranyl Acetate 
and Lead Citrate then viewed in a Philips CM120 Transmission electron microscope.  
Images were taken on a Gatan Orius CCD camera. All chemicals were sourced from TAAB 
Laboratories Equipment Ltd. Percentage myelinated axon counts were performed on all 
images to prevent selective bias and graphs and statistical tests were generated using 
weighted averages for the relative contribution of total number of axons for at least 3 
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biological replicates of each genotype imaged. g-ratio of random samples of axons were 
obtained using the g-ratio ImageJ plugin (Goebbels et al. 2010).  
2.2.10 Immunofluorescence of tissue and cells  
For all antibody conditions10μm frozen sections were warmed to room temperature, or 10 
minute 4% PFA fixed coverslips containing cells were washed in PBS and then blocked in 
4% bovine serum albumin (Sigma) for 1 hour and then stained overnight at 4°C with 
appropriate antibodies (see table) in blocking solution with 0.2-0.3% Triton X 100 (Sigma). 
Samples were then washed in PBS before secondary staining for 1hr at room temperature 
and stained with 1µg/ml DAPI (Sigma). All solutions dissolved in PBS. Comparative cell 
counts were performed with each channel threshold at the same value in controls and 
experimental conditions to ensure consistent positive scoring. Graphs and statistical test 
were generated using weighted averages for the relative contribution of total cells for at least 
3 biological replicates of each genotype imaged. 
2.2.11 Tissue RNA isolation and cDNA synthesis 
Optic nerves from P14 and P90+ animals were added to TRIzol (Ambion) and snap frozen 
before storage at -70°C. Tissue was homogenised in pools of 4-6 optic nerve pairs per 
genotype using a dounce homogeniser. RNA was then isolated using Directzol Microprep kit 
(Zymo Research) or RNase easy miniprep kit (QIAGEN) according to manufacturer’s 
instructions.  
2.2.12 Gene expression analysis by qPCR 
Reverse transcription to cDNA was carried out using SuperScript II and IV enzymes (Life 
Technologies) using oligo d(T) primers according to reagent manufacturer’s instructions. All 
analyses of experimental conditions were matched with littermate controls with RNA isolated 
and cDNA synthesised by the same procedure. 
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Isolated cDNA was analysed by qPCR using the Roche 480 Light cycler system with 
manufacturer supplied master mix and either 384 or 96 well plates. All expression levels 
were normalised to Gapdh expression in each sample and shown as log2 fold change in 
experimental genotypes, relative to gene expression in control cDNA.  Data represents the 
average of 3 technical replicates (6 total) of 2 biological replicate cDNA pools, generated 
from the same number of animals for each genotype.  
2.2.13 Oligodendrocyte Isolation 
1-day prior isolation positive selection plates were coated with Goat Anti-Rat IgG (H+L) 
solution in PBS and negative selection plates in BSC1 and incubated overnight at 4⁰C. On 
day of dissection, solution was removed from positive selection plates and washed in PBS 
before addition of αCD140a antibody in 0.2% BSA PBS solution. Mouse brains were 
dissected, along with meninges, and a single cell suspension was obtained using MACs 
neural dissociation Kit P (Miltenybiotec) according to manufacturer’s instructions. 
Suspension was passed through a 70µm strainer and 10ml HBSS was added, this was then 
spun down 300xG for 5 mins and resuspended in 7ml panning buffer before incubation on a 
washed negative selection plate for 15 mins. Not selected cells in suspension were then 
transferred to a positive selection plate for 45 minutes at room temperature. Not selected 
cells were discarded (or retained for DNA isolation). The plate was then washed 10 times in 
PBS and cells were either scraped in OPC medium before plating and culture or harvested 
directly from the positive section plate. 
2.2.14 RNA-Seq Library preparation 
RNA was isolated as previously described from 3 pools of 6 optic nerves and brain samples 
alongside from a mixture of all 6 mice in each pool. Quality of RNA was then assessed by 
running on brain RNA on 1.5% agarose gel at 200V for 15 mins in TAE buffer to assess 
quality via integrity of the ribosomal RNA bands. Libraries were then generated from the 
100-200ng yeild from each pool using the TruSeq® Stranded Total RNA Library Prep kit with 
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Human/Mouse/Rat rRNA illumination beads (Illumina). 15 amplification cycles were used as 
recommended for low sample input. Libraries were then assessed for quality using the 
bioanalyser 2100 expert High Sensitivity DNA Assay (Agilent) kit according to 
manufacturer’s instructions pooled and sent for sequencing on 2 lanes of an illumina HiSeq 
4000 150PE by Edinburgh Genomics. 1 control library contained reads mapping to no 
annotated sequence and as a result this and its littermate control were discarded from 
analysis. 
2.2.15 Whole genome bisulphite sequencing library preparation 
DNA was isolated from OPCs derived from 3 separate mice per genotype (Lsh+/off;Pdgfrα-
Cre, Lshoff/off;Pdgfrα-Cre and Lshoff/off) as described earlier. Concentration was then 
measured using Qbit BR DNA assay and kit according to manufacturer’s instructions and 
1µg DNA input into bisulphite conversion using EZ DNA Methylation-Gold kit (Zymogen) 
according to manufacturer’s instructions. Libraries were then generated from this DNA using 
TruSeq® DNA Methylation Kit using 10x amplification cycles according to manufacturer’s 
instructions. Libraries were then assessed for quality using the bioanalyser 2100 expert High 
Sensitivity DNA Assay (Agilent) kit according to manufacturer’s instructions pooled and sent 
for sequencing on 2 lanes of an illumina HiSeq 4000 150PE by Edinburgh Genomics. 1 
control library contained reads mapping to no annotated sequence and as a result this and 
its littermate control were discarded from analysis. 
2.2.16 Differential expression analysis stage specific comparisons 
Quality control for libraries was performed on raw data using FastQC v0.112 and 
Trimmomatic v0.32 to trim low quality and adapter sequences. Remaining reads were then 
mapped to the mm10 mouse reference transcriptome using STAR v2.5.3a and transcript 
abundance was quantified with Salmon v0.11.4. Differentially expressed genes between 
Lsh+/off and Lshoff/off were called using DESEQ2 v1.22.1 from the estimated read counts 
output by Salmon. Gene annotations were obtained from the Ensembl database v79. 
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CNS cell type specific genes were called from RPKM values derived from the Barres brain 
database (Zhang et al. 2014). Each cell type present in the database were assigned a ratio 
between RPKM value in the cell type to the mean RPKM in all other cell types. For each cell 
type genes were then ranked by this ratio and the top 100 deemed specific for a given cell 
type. In the assignment of genes to different regulatory stages in OL differentiation, stages of 
regulation and rat genes within those stages were defined in the route publication (Swiss et 
al. 2011). Mouse homologues for the rat genes were then identified by cross referencing 
gene names in the Ensembl database. All genes which did not have a mouse homologue 
were excluded from the analysis. Cell type characteristic genes defined by single cell RNA-
seq were extracted directly from the route publication (Marques et al. 2016). Gene ontology 
analysis was performed using g-profiler v0.6.7 on genes identified to be significantly 
changed (p-value <0.05) in each direction. All graphs were produced using R in R-studio and 
analysis was performed by Shaun Webb (Wellcome centre for cell biology bioinformatics 
core facility) under my direction.  
2.2.17 Whole genome bisulphite sequencing analysis 
Quality control for libraries was performed on raw data using FastQC v0.112 and 
Trimmomatic v0.32 to trim low quality and adapter sequences. Surviving reads were then 
aligned to the mouse mm10 reference genome using Bismark v0.19.0 and CpG methylation 
and coverage values were provided in the output.  Percentage CpG methylation was then 
calculated for 1kb regions across the genome and these regions were classified based on 
proximity to annotated genomic features, using ChIPpeakAnno v3.16.0 and the 
org.Mm.eg.db annotation package in R using the default priorities for feature assignment.   
Significantly differentially methylated regions (DMRs) between each possible pair of 
condition sequences were called using DMRseq v1.2.1. These DMRs were then manually 
filtered to remove regions mapping to the Y chromosome and random contigs. (DMRs were 
then assigned to genomic features as above. All graphs were produced using R in R-studio 
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and analysis was performed by Shaun Webb (Wellcome centre for cell biology bioinformatics 




3. Results- Chapter Three- Conditionally 
Reversible LSH Knock-Out in Mice 
3.1 Introduction 
Chao Li produced two independent mouse lines from separate ESC clones. Both of these 
lines produced viable Lsh+/off germline converted chimeras, which were crossed into C57Bl/6 
background (F1) to generate the strains TV1 and TV2. Animals were not backcrossed 
C57Bl/6 background for multiple generations so remained largely on a mixed 
129/Ola/C57Bl/6 background. A surprising initial observation given previously reported 
perinatal lethality for  Lsh-/- (Geiman et al. 2001) Lsh+/off x Lsh+/off crosses using both strains 
produced Lshoff/off progeny that survive until weaning. Given this result, the importance of the 
first step in achieving my initial aim of characterising any Lshoff/off phenotype of quantifying 
the extent of ablation Lsh mRNA and LSH protein in Lshoff/off was highlighted as the most 
simple explanation for lack of perinatal lethality is incomplete knock-out. Recombination 
mediated conditional alleles generated with the aim of altering protein expression rely on the 
ability of the splice acceptor (SA) within the inserted cassette to force incorporation of the 
polyadenylation signal and cause truncated mRNA transcription from the locus. Complete 
abolition of protein expression requires no skipping of the SA, as this would result in full-
length mRNA transcription and subsequent translation. In addition, incorporation of the 
inserted cassette in mRNA followed by subsequent splicing into the next exon upstream of 
the polyadenylation signal would cause production of a potentially functional fusion protein. 
Because LSH is an enzyme, small amounts of protein produced from a hypomorphic allele 
has the potential to alter a large proportion of its in vivo substrate. Previous hypomorphic 
mutations in Lsh that completely abolish ATPase function and greatly reduce protein 
expression also survive postnatally, proving conceptually that even small levels of non- LSH 
function remaining could prevent perinatal lethality (Sun et al. 2004). These two factors 
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combined with the high levels of redundancy present within systems regulating chromatin 
structure would make dissection of LSH’s in vivo function difficult using a hypomorphic allele. 
3.2 LSH expression is abolished in Lshoff/off and is restored 
in Lshon/on 
3.2.1 Full length Lsh protein coding transcript is reduced in Lshoff/off  
To quantify the extent of knock-out in Lshoff/off at the mRNA level and test if splice variants 
including the GFPneo-cassette were present in mRNA produced from the Lshoff allele I first 
decided to look in mouse embryonic stem cells (ESCs). When the initial Lsh+/off lines were 
generated in the Stancheva lab, as previous mouse knockouts of Lsh displayed an 
exclusively recessive phenotype (Geiman et al. 2001), these cells were targeted again using 
the initial homologous recombination vector to produce a homozygous Lshoff/off line for 
characterisation of any potential ESC phenotype. As Lsh expression is under the control of 
an E2F promoter and ESCs spend a large proportion of time in the dividing cell cycle, these 
cells express LSH at a high level (Raabe et al. 2001, Fan et al. 2003). I reasoned that if 
unexpectedly spliced variants of Lsh mRNA were produced, it will be at a lower level than 
the GFP-neo-stop fusion mRNA due to the relative strength of the Engrailed splice acceptor 
and its widespread use in other systems (Voss et al. 1998, McClive et al. 1998). Due to the 
limited sensitivity of any method to look at gene expression, I would also have the maximum 
chance of detecting improperly spliced transcript where the promoter was most active.  
To this end, I isolated total RNA from the double targeted Lshoff/off ESCs and the parental 
Lsh+/+ E14 ESC line. Polyadenylated mRNA was then reverse transcribed into cDNA using 
Oligo d(T) primers and PCR performed using primers specific for exon 3, immediately 
upstream of the GFP-neo-stop cassette and a combination of the short exons 4 and 5. Any 
products present in the Lshoff/off PCR would indicate transcripts that would have improperly 
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spliced through the GFP-neo-stop to downstream exons, and those larger than 82bp would 
indicate the presence of the cassette in a fusion mRNA that may be functional (Fig. 3.1A). 
I performed qPCR on Lshoff/off and Lsh+/+cDNA. This revealed approximately 3% of 
improperly spliced transcript being produced in Lshoff/off, significantly more than in controls 
lacking reverse transcriptase in the cDNA synthesis reaction (Fig. 3.1B). However, analysis 
of the melt curves from the products these samples indicate a lower Tm of product present in 
Lshoff/off, which is not consistent with splicing through the cassette to produce a larger 
product. A more sensitive technique to look further into what was being produced from the 
Lshoff/off locus would be northern blotting using a probe either for exons 4 and 5 or GFPneo, 
however as large amounts of protein producing transcript has been ruled-out, I prioritised 




Figure 3-1 qPCR for products spanning insertion cassette of the Lshoff allele shows Lsh+ transcript 
expression abolished 
A) Schematic representation of PCR products made from cDNA in the scenarios of (top) wildtype Lsh 
mRNA being produced and (bottom) the engrailed splice acceptor being read through, or cryptic 
splice acceptors used within the Gfpneo cassette insertion. Such a large product is unlikely to be 
detectable under the same qPCR conditions as the 82bp product. 
B) qPCR signal from reverse transcribed ESC mRNA across Lsh genotypes and RT conditions. Left 
graph with contiguous axes and right with split to show levels of expression in conditions producing 
less product that Lsh+/+. T-tests with Welch’s correction were used to calculate significance, n.s 
signifies not significant, ****= p<0.00001, ***= p<0.0005, **=p<0.005. Bars represent mean and error 




3.2.2 As low as 3% of LSH expression in Lsh+/+ ESCs is detectable by western blot. 
To investigate the extent to which the Lshoff/off allele abolishes protein expression, the 
sensitivity of currently available antibodies for LSH protein in western blots first needed to be 
determined. In order to determine this sensitivity, I needed to assess the minimum proportion 
of protein from wild-type cells detectable in the assay. To increase sensitivity of detection, a 
protein extract from a source for which a comparison between Lsh+/+and Lshoff/off could be 
made and that would have high levels of LSH is also required.  
To achieve this, Irina Stancheva prepared nuclear protein extracts from E13.5 embryos (see 
previous section for reasoning). To control for differing efficiency of transfer to nitrocellulose 
membranes depending on protein concentration present, nuclear protein from Lsh+/+ 
embryos and Lsh-/- MEFs, a previously established knock-out of LSH generated by an 
independent laboratory (Geiman et al. 2001), was mixed in differing ratios of Lsh+/+ nuclear 
extract with Lsh-/- MEF nuclear extract. 60µg of these dilutions and were loaded to an 
acrylamide gel along with Lshoff/off embryo nuclear extract.  Equality of loading was confirmed 
by probing with a αHDAC1 antibody (Fig. 3.2A). The same membrane was then probed 
using 3 different antibodies raised to different regions of the LSH protein. LSH was 
detectable to the minimum proportion of Lsh+/+nuclear extract tested (3%) using the N-
terminal rabbit polyclonal antibody and was undetectable in Lshoff/off extract under optimal 
exposure for quantification (Fig.3.2B). Probing for other antibodies resulted in less sensitive 
detection, but in no condition was LSH detected in Lshoff/off extract (Fig3.2C, D). No antibody 
condition was able to detect any LSH protein in the previous knock-out. Following on from 
this I used the same approach for Lsh+/+ and Lshoff/off ESCs to see if any protein was 
detectable in a more highly expressing cell type. Again, LSH was detectable up to the 3% 
dilution, but this time even with the less sensitive mouse monoclonal antibody (Fig.3.2E). 
From these experiments I concluded that Lshoff/off knocks-out at least 97% of LSH protein in 
mouse embryos, and possibly more limited by the sensitivity of the assay.  
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 Figure 3-2 Western blot titrations determining LSH antibody sensitivity shows at least 97% 
depletion of LSH in Lshoff/off 
A) Staining for HDAC1 on a nitrocellulose transferred SDS-PAGE gel loaded with decreasing 
concentrations of Lsh+/+ embryonic extract, mixed with increasing concentrations of Lsh-/- extract. 
B) Schematic representation of epitope location of a mouse monoclonal antibody used to stain the 
membrane shown in (A). Signal is detectable up to 12.5% of Lsh+/+ extract, with no increase in 
background at higher molecular weight. 
C) As (B) but showing the epitope of a rabbit polyclonal antibody. Signal detectable to 3% with low 
background in all lanes. 
D) As (B) and (C) with schematic showing epitope for rabbit polyclonal antibody raised to a more c-
terminal region of LSH, again protein datable to 3% of Lsh+/+ levels with no increase in background 
or higher molecular weight bands in Lshoff/off. MW indicated in kDa on A-D. 
E) A blot of mouse ESC protein extracts loaded in the same titration scheme as described above 





3.2.3 LSH expression is abolished in MEFs derived from Lshoff/off mice and restored 
in MEFs derived from mice converted to  
The western blot titration experiment only looks at expression in 1 individual Lshoff/off animal 
and the double target ESC line. It is conceivable clonal variation between the lines that were 
used to generate Lshoff/off animals and genetic background may have an impact on LSH 
expression. It is also necessary to test if conversion to Lshon/on (Fig. 1.1) is capable of 
restoring LSH expression to Lsh+/+ levels as intended. One possibility that would lead to 
reduced expression of full length LSH, or production of a fusion protein with impaired 
function, is the presence of the GFPneo-stop cassette leading to unexpected splicing events, 
even following change in orientation. 
To address these possibilities, I used primary MEF cell lines isolated from Lshoff/off, Lsh+/off, 
Lsh+/+ and Lshon/on mice by Natalia Torrea, another PhD student in the former Stancheva lab. 
Lsh+/on mice were generated from crossing of the TV2 Lsh+/off line into a line possessing 
constitutively expressed FLPo recombinase (C57BL/6-Tg(CAG-Flpo)1Afst/Ieg). Progeny 
from this cross possessing Flpo and therefor considered converted to Lsh+/on, were then 
crossed into Lsh+/+ mice to remove the Flpo allele. Non-littermate Lsh+/on progeny from this 
cross were then crossed to produce Lshon/on animals. MEFs were used for testing the 
expression of LSH because large amounts of material could be collected from them and the 
relatively high level of expression compared to tissue from mice.  Primary MEF cell lines 
were readily available from Natalia’s project and due to their retained ability to undergo 
cellular senescence and limited number of divisions following isolation from the animal, may 
be less prone to potential artefacts associated with immortalisation and prolonged growth in 
culture (such as aneuploidy). 
qPCR on all the lines tested surprisingly revealed Lsh expression around 12% of Lsh+/+ in 
Lshoff/off and importantly Lshon/on cells have restored Lsh expression and Lsh+/off expression is 
approximately 50% of Lsh+/+. I speculate that due to much lower levels of expression in 
59 
 
MEFs, variability between samples is much higher than in ESCs. Interestingly detection of 
transcript in Lsh-/- MEFs suggests a non-protein coding transcript may be produced including 
this splice junction in these cells (Fig. 3.3A). Any conclusion beyond reduction in transcript in 
Lshoff/off and restoration in Lshon/on would require further experiments (such as the northern 
blot suggested in the previous section) due to the limitation of this PCR, especially at the 
lower levels of transcript present in MEFs. 
To determine sensitivity of LSH protein detection I performed a similar titration to that 
described in the previous section. I mixed nuclear extract from Lsh+/+ primary MEFs with the 
Lsh-/- previously published immortalised line, with a decreasing ratio of Lsh+/+ material in 
each tested sample. This revealed LSH expression was detectable up to approximately 6% 
of Lsh+/+ levels, less than that possible in ESCs, likely due to increased promoter activity due 
to MEF’s slower division rate (Fig.3.3B). To address the issue of possible clonal variation or 
genetic background effecting LSH expression in Lshoff/off and whether protein expression is 
restored in Lshon/on I did a western blot of nuclear extract on 2 MEF lines from Lshoff/off and 
Lshon/on mice. These support the evidence from the titration experiments that LSH is not 
detectable in Lshoff/off and that LSH expression is restored in Lshon/on from the qPCR and 





Figure 3-3 qPCR and western blot analysis for primary MEF cell lines replicates protein abolition in Lshoff 
observed in embryos and restoration of LSH expression in Lshon 
  
A)  qPCR using splice junction specific primers for cDNA derived from Lsh mRNA in primary MEF cell 
lines. Bars represent mean and error bars standard (n=3). 
B) Staining for LSH using n-terminal rabbit polyclonal antibody and HDAC1 on a nitrocellulose 
transferred SDS-PAGE gel loaded with decreasing concentrations of Lsh+/+ primary MEF extract, 
mixed with increasing concentrations of Lsh-/- extract and Lshoff/off MEF extract. Panel on right shows 
equal loading by ponceau staining. 
C) Staining for LSH using n-terminal rabbit polyclonal antibody and HDAC1 on a nitrocellulose 
transferred SDS-PAGE gel loaded with Lsh+/+, 2 Lshoff/off and 2 Lshon/on primary MEF cell lines. Panel 




3.3 Lshoff/off mice survive to adulthood but are not healthy. 
This phenotype is rescued in Lshon/on 
Initial expectations in the Stancheva lab on production of Lshoff/off mice were that, like the 
previous global knockout of the gene, this genotype would result in perinatal lethality. The 
strategy for dissecting LSH’s function in development would therefor revolve around analysis 
of embryos and restoring and abolishing expression protein in specific tissues at different 
developmental stages and study potential phenotypes that arose. This surprisingly proved 
not to be the case. 
3.3.1 Lsh+/off animals are fertile whereas Lshoff/off mice are sterile and survive to 
adulthood to varying extents depending on genetic background.  
In order to investigate the viability of mouse strains with the Lshoff allele, I have analysed all 
data on the litter sizes produced from crosses of various genotypes. Crossing of 
heterozygous Lsh+/off (Lsh+/off × Lsh+/off) animals within the 129/Ola/C57Bl/6 mixed 
background produces litters of sizes comparable to Lsh+/off × Lsh+/+ crosses (Fig. 3.4A). 
Altering genetic background from that of the initial chimeras by crossing Lsh+/off strains into 
the C57BL/6/CBA Tg(CAG-cre/Esr1*)5Amc strain (hereby termed LSH ER-CRE, Allele 
termed TgEr-Cre) and the (129X1/SvJ x 129S1/Sv)F1-Kitl+ Gt(ROSA)26Sor strain (termed 
LSH ROSA26 ER-CRE, allele termed Rosa26Er-Cre) also doesn’t significantly affect litter 
sizes (Fig. 3.4A). To see if the perinatal lethality phenotype seen in previous Lsh knockouts 
was observable in the Lshoff lines, I analyzed the proportion of mice born surviving until 
weaning across our strains. Interestingly, this revealed a small but statistically significant 
decrease in proportion of mice making it to weaning in Lsh+/off; TgEr-Cre x Lsh+/off compared 
to Lsh+/off x Lsh+/+ and Lsh+/off x Lsh+/off compared to Lsh+/off × Lsh+/+ but not Lsh+/off; Rosa26Er-
Cre (Fig.3.4B). Chi-squared analysis of genotypes produced from the 4 crosses shows that 
there is a significant reduction in Lshoff/off animals from the expected Mendelian ratio in 
Lsh+/off × Lsh+/off and Lsh+/off; TgEr-Cre x Lsh+/off, but not Lsh+/off × Lsh+/+ or Lsh+/off; Rosa26Er-
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Cre x Lsh+/off (Fig.3.4C, D, E, F). Suggesting that significantly more lethality exists in the 
Lshoff/off before weaning than Lsh+/off when large numbers of mice are analysed (n=767). The 
fact that this is detectable in Lsh+/off; TgEr-Cre x Lsh+/off and not Lsh+/off; Rosa26Er-Cre 
despite similar numbers of mice being analysed (n=166 and n=131 respectively), also 
suggests some effect of this line’s background in exacerbating this lethality. 
  
Figure 3-4 Lsh+/off crosses produce homozygous Lshoff/off progeny to a normal Mendelian ratio dependent 
on genetic background 
A)  Boxplots showing litter sizes from Lshoff crosses in different genetic backgrounds. P-values are the 
result of unpaired t-tests on comparisons of conditions. Whiskers representative of upper and lower 
quartiles, n=39, 120, 28 and 28 litters respectively. 
B) Boxplots showing percentages of mice born across Lshoff line crosses. P-values sre the result of 
Mann-Whitney non-parametric tests due to non-normal distribution present in samples. Bounds of 
boxes represent minimum and maximum values, n numbers as with (A) 
C) Observed and expected rations of mice born from Lsh+/+ × Lsh+/off crosses.  
D) Observed and expected rations of mice born from Lsh+/off × Lsh+/off crosses.  
E) Observed and expected rations of mice born from Lsh+/off × Lsh+/off;TgEr-Cre crosses.  
F) Observed and expected rations of mice born from Lsh+/+ × Lsh+/off; Rosa26ErCre crosses. 







3.3.2 Lshoff/off mice have growth retardation, ataxia and tremor phenotypes that are 
rescued in Lshon/on. 
In order to address the first aim of my thesis, I now set out to see if there was any obviously 
phenotypes in Lshoff/off animals which would prove amenable to more in-depth study. 
Early observation of Lshoff/off mice revealed an obvious tremor and ataxia phenotype (see 
appendix video 3), which often led to animals being culled due to welfare concerns. Mice 
were lean and slightly decreased length compared to Lsh+/off littermates (Fig.3.5A). Another 
immediate observation was that Lshon/on animals are fertile, but Lshon/on x Lshon/on crosses 
produce reduced litter sizes compared to other lines, though a similar proportion make it to 
weaning as Lsh+/off × Lsh+/+ and significantly higher proportion than Lsh+/off × Lsh+/off 
(Fig.3.5B). To analyse the extent of the reduced body weight and growth phenotype, I have 
plotted combined weekly weights across monitored litters in Lshoff and Lshon mouse lines. 
Lsh+/off and Lshon/on mice show a growth in body weight comparable to Lsh+/+ animals, but 
Lshoff/off males and females have a reduction in growth from approximately 5 weeks post-
weaning, followed by a gradual decline immediately in males starting at week 9 for females 
(Fig. 3.5C). As a large proportion of Lshoff/off animals were being found dead post-weaning, 
the severity of the body weight and neurological phenotype were monitored according to a 
scoring system (see materials and methods) for all homozygous animals across Lshoff and 
Lshon lines, and a humane endpoint defined.  Data from all maintained mice shows survival 
of Lshoff/off animals starts to drop around 7 weeks post-weaning onwards, with no death seen 
in the other genotypes within this timeframe (Fig.3.5D). We did not continue maintaining 
mice beyond 10 weeks to determine maximum Lshoff/off survival as priority was given to other 
experiments that required mice before endpoint was reached. Plotting neurological scoring 
of Lshoff/off, Lshon/on and Lsh+/off animals reveals a large variation in severity of Lshoff/off 
phenotype, though it was apparent in all but 1 of 24 animals immediately post-weaning. 
Importantly there is also no phenotype observable in non-Lshoff/off genotypes, indicating this 







Figure 3-5 Lshoff/off has a growth retardation, neurological and survival phenotype that is rescued in 
Lshon/on 
 
3.3.3 Adult Lshoff/off mice DNA is hypomethylated in multiple tissues and Lshoff/off 
mice have atrophied optic nerves and other organs show  
To investigate if Lshoff/off mice have a functional knock-out of LSH in vivo and narrow down 
the location of a cellular cause for the observed phenotype, tissue was dissected from 
Lshoff/off and Lsh+/off control animals and analysed. An immediate observation was, strikingly, 
optic nerves from Lshoff/off mice are smaller than their heterozygote counterparts and appear 
almost transparent in phenotypically severe animals (Fig. 3.6A). Notably, although there is a 
reduction in girth, this transparency is not observable in the peripheral nervous system 
sciatic nerve in the same animal (Fig.3.6B). It’s important to note though, other organs differ 
morphologically depending on genotype, with spleen much smaller and paler colour in 
Lshoff/off animals (Fig.3.6C). 
 To address if LSH is functionally knocked-out, I isolated gDNA from brain, spleen and 
kidney and sent for HPLC to determine 5-methyl-cytosine (5mC) content relative to cytosine. 
This shows hypomethylation of DNA compared to Lshoff/off from around 70% of Lsh+/off in 
brain to around 60% in spleen (Fig. 3.6C). In addition, we looked at the presence of 5-
hydroxymethyl cytosine, a read out for the dynamic removal of 5mC (Pastor et al. 2013), 
which interestingly showed the greatest disparity in spleen (Fig. 3.6D), the tissue with the 
greatest proportion of rapidly dividing cells (Bachman et al. 2014). 
A) Boxplots showing litter sizes from Lshon and Lshoff crosses. P-values result on unpaired t-test 
comparisons of conditions. Whiskers representative of upper and lower quartiles, n=39, 120 and 34 
respectively. 
B) Boxplots showing percentages of mice born in Lshon and Lshoff crosses. P-values the result of Mann-
Whitney non-parametric tests due to non-normal distribution present in samples. Bounds of boxes 
represent minimum and maximum values, n numbers as with (A) 
C) Line graph of mean weights post-weaning for females of Lsh+/+, Lshon and Lshoff genotypes. Error 
bars show standard deviation, maximum n numbers=10, 48, 39 and 4 respectively, though this 
varies between timepoints for the first 3 genotypes due to culling and deaths. 
D) Line graph of mean weights post-weaning for males of Lsh+/+, Lshon and Lshoff genotypes. Error bars 
show standard deviation, maximum n numbers=12, 41, 46 and 6 respectively though this varies 
between timepoints for the first 3 genotypes due to culling and deaths. 
E) Scatter plot of neurological score for Lsh+/+, Lshon and Lshoff genotypes, maximum n numbers=13, 
89, 109 and 8 respectively though this varies between timepoints for the first 3 genotypes due to 





Figure 3-6 There are morphological and DNA methylation phenotypes across Lshoff/off tissues 
  
A) Light microscopy image of P90 Lsh+/off and Lshoff/off optic nerve. 
B) Light microscopy image of P90 Lsh+/off and Lshoff/off sciatic nerve (same animal as above). 
C) Light microscopy image of 2 P90 Lsh+/off and Lshoff/off spleens. 
D) HPLC analysis of 5 methyl-cytosine in DNA isolated from Lsh+/off and Lshoff/off tissue.  
E) HPLC analysis of 5’ hydroxymethyl-cytosine in DNA isolated from Lsh+/off and Lshoff/off tissue.  
Bars on D and E represent a mean of 5mC or 5hmC percentages normalised to Lsh+/off levels 
respectively (mean considered 100%) error bars show standard deviation (n=3) and P-values 






There is detectable signal in PCR using primers either side of the wild-type mRNA exon 
3,4,5 splice junction in Lshoff/off ESCs, though melt curve analysis shows this is not the result 
of wild-type Lsh transcript production.  Likely due to lower expression levels, this Lshoff/off 
product is not above the level of noise in MEF cDNA. LSH protein is reduced at least 94% in 
Lshoff/off MEFs and 97% in Lshoff/off ESCs.  In these conditions, full length LSH, or a fusion 
protein of LSH and the protein product of the inserted GFPneo cassette is not detectable. 
This reduction or abolition in LSH is sustained in Lshoff/off across variation in genetic 
background. Breeding of Lshoff possessing mice into an FLPo strain leads to restoration of 
LSH expression at the RNA and protein level in progeny homozygous for SA-GFPneo-STOP 
insertion. This suggests inversion of the cassette successfully abolishes SA recognition, 
allowing full-length protein to be produced. Lshoff/off embryos can make it to term and genetic 
background does have some effect of Lshoff/off viability. Due to the differences between the 
LSH ER-CRE and LSH ROSA26 ER-CRE insertions, the difference in post-natal viability 
observed could be due to differing doses of CRE/ESR1 fusion protein caused by multiple 
insertions of the CAG-cre/Esr1 transgene. In addition, differences in expression between the 
Cag and Sor promoters rather than the differing strain backgrounds introduced to Lsh+/off 
could be responsible for altered lethality. Nonetheless, the ability to breed a more perinatal 
lethality-like phenotype into Lshoff strains hints that through more extensive backcrossing of 
lines the Lsh-/- phenotype could be recapitulated in our knockout lines 
As it’s not possible to confirm 100% LSH knock-out in Lshoff/off mice, the argument can 
always be made that any phenotype present in these mice that differs from previous reports 
of a widely accepted Lsh knock-out are due to tiny amounts of residual functional protein 
being present. However, as discussed earlier, recently mutations in the human Lsh gene 
(Hells), that truncate LSH protein early into the protein and abolish all characterised 
enzymatic activity and functional domains, have recently been associated with ICF 
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syndrome (Thijssen et al. 2016). This shows that functional Lsh knock-out is compatable 
with post-natal mammalian life, making the prospect less unreasonable to be true also in 
mouse. Also encouraging levels of methylation in Lshoff/off seem to be similarly reduced to 
previous lines. Mice also develop and unexpected neurological phenotype, which intriguingly 
fits with previously characterized lines lacking nervous system myelination (Orian et al. 
1994). In order to fulfil the aims of my project I chose to focus on characterizing the cellular 
defects present in this phenotype in Lshoff/off animals, and to see if there truly is a lack in 







4. Results- Chapter Four- LSH Knock-out Leads 
to Hypomyelination and an Oligodendrocyte 
Differentiation Defect  
4.1 Introduction 
To test the hypothesis that the ataxia and tremor phenotype was in fact due to myelination 
and try and narrow down when and where LSH expression was essential for this process, I 
needed to perform a rigorous characterisation of myelin throughout the central nervous 
system. Characterisation of the precise defect, which could be due to a mechanical inability 
for differentiated cells to produce or wrap myelin, an inability for cells to properly differentiate 
or survive due to intrinsic or extrinsic factors, or because neurons themselves are not 
amenable to myelination, would also shed light on the cellular cause of the Lshoff/off 
phenotype. The most sensitive way to achieve this characterisation is through transmission 




4.2 Lshoff/off mice have reduced myelination throughout 
development, but to differing extents depending on 
axonal/tissue specific environments 
4.2.1 Lshoff/off mice have substantial hypomyelination throughout adulthood, 
specifically in the central nervous system 
I performed transmission electron microscopy (TEM) on osmium tetroxide stained sections 
of post-natal day 90 optic nerve, corpus callosum and spinal cord from Lshoff/off  and Lsh+/off  
animals, to control for any dominant negative effect of the LSH-GFPneo fusion protein may 
have on myelination. Example images show there is indeed an obvious lack of myelin (dark 
staining regions) wrapped around axons (circular cross sections) in all the CNS tissues 
tested (Fig. 4.1A, B, C). To test if this was due to an in ability of all cells to synthesis the 
components of myelin, or a problem specific to OLs, the myelinating cells of the CNS, I also 
performed TEM on sciatic nerves, a peripheral nervous system tissue myelinated by 
Schwann cells. There was no obvious difference between genotypes (Fig. 4.1D). 
However, some myelination was still visible in Lshoff/off indicating the presence of some 
mOLs. To be confident that this phenotype was apparent across animals in the population, 
and to get a better indication of the amount of residual myelin, I counted the proportion of 
myelinated axons in a sample of 200 axons per animal in the optic nerve and spinal cord of 3 
individuals per genotype. This revealed the extent of myelination differs quite widely between 
more and less severely affected Lshoff/off animals, (Fig.4.1E). In addition, it appears as 
though spinal cord in Lshoff/off is substantially more myelinated (in terms of percentage with 
any myelin) than optic nerve. An important aspect of the phenotype that can hint at the role 
of LSH in myelination is whether the ability to establish myelin in development is impaired, or 
whether there is a loss following aging. The former would suggest a differentiation defect, or 
large-scale death in the OL population and the latter that LSH is important for long-term OL 
survival. To distinguish between these two possibilities, I performed TEM on optic nerves 
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from P24 animals, which normally represents the peak of developmental myelination (Foran 
and Peterson 1992). A lack of myelination analogous to those in older animals was 
observable in example images in optic nerve, although again spinal cord appears to be less 
severely affected (Fig.4.1F).  
It is unclear from the percentage myelinated axon analysis if the Lshoff/off hypomyelination is 
the result of individual variation, or a variegated pattern of myelination across the CNS of 
Lshoff/off animals, and the small region sectioned in a given individual happening to be 
relatively well myelinated. When looking at a few images of corpus callosum from the same 
Lshoff/off animal, small patches where more myelin is present are observable that might be 
consistent with a variegated phenotype (Fig.4.1G). However, I chose not to perform a more 
rigorous analysis into whether this is consistent with variegation, due to the overwhelmingly 
phenotype present even in less severely affected Lshoff/off animals, and instead chose to 
focus more on the cellular cause of the phenotype. 
  
Figure 4-1 Lshoff//off animals are hypomyelinated throughout the CNS throughout development but retain 
myelin in the PNS 
A) Representative TEM images of myelin in P90 Lsh+/off and Lshoff/off optic nerve 
B) Representative TEM images of myelin in P90 Lsh+/off and Lshoff/off corpus callosum 
C) Representative TEM images of myelin in P90 Lsh+/off and Lshoff/off spinal cord 
D) Representative TEM images of myelin in P90 Lsh+/off and Lshoff/off sciatic nerve 
E) Mean percentage myelinated axons in Lsh+/off and Lshoff/off tissue from a sample of 200 axons from 3 
individuals, error bars represent S.E.M and p-values calculated using unpaired t-tests between 
genotypes within a tissue. *=P<0.05. 
F) Representative TEM images of myelin in P24 Lsh+/off and Lshoff/off optic nerve and spinal cord 
G) Images of P90 Lshoff/off corpus callosum illustrating the variation in myelination across different 








4.2.2 Lshoff/off mice have a similar axon density and calibre range to Lsh+/off but the 
relationship between axon calibre and myelination is maintained only for 
larger axons.  
One feature of myelin is the tendency for larger diameter axons to be more likely myelinated 
and to a greater thickness than smaller axons (Hildebrand et al. 1993). When this 
relationship breaks down, it can indicate an impairment of  response to differentiation signals 
secreted by axons or for axons to secrete these signals (Makinodan et al. 2012, Mensch et 
al. 2015, Almeida et al. 2011). To investigate if these are factors influencing the Lshoff/off 
phenotype I measured percentage of myelinated axons in the Lshoff/off optic nerve in various 
ranges of axon calibre. Larger calibre axons are not significantly more likely to be myelinated 
than small calibre ones in optic nerve (Fig.4.2A). This may be due to the earlier discussed 
lack of ability to react to axon signalling from the relatively low diameter of axons present in 
the optic nerve or could be due to another factor in the tissue environment. Therefor to test if 
axon diameter could be sensed at larger sizes and in other tissues, I performed similar 
analysis on the larger axons in the spinal cord. Here we can see that at the largest axon 
strata, calibre does influence myelination, with >0.7μm2 axons being myelinated to a much 
greater extent than smaller axons, and more even than comparable sizes in optic nerve (Fig. 
4.2B).  
The conclusion from myelination analysis is the result of an OL defect could be confounded 
by differences in axon density and size between Lshoff/off and Lsh+/off. It is conceivable the 
Lshoff/off neurological phenotype is the result of an inability of neurons to develop and form 
effective networks in the CNS, independently of myelin. This could, in turn, have a knock-on 
effect on myelination. An observation consistent with this would a reduction in axon density 
or size in Lshoff/off. To test this hypothesis, I measured the frequency of neurons across 
different axon calibres in our 200 axon/animal samples, along with total density of axons in 
Lshoff/off optic nerve and spinal cord compared to Lsh+/off. There is no significant difference in 
size distribution of axon calibre in the sampled axons measured (Fig.4.2C, D). Density of 
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neurons in Lshoff/off tends to be higher than Lsh+/off though this difference is not statistically 
significant in either tissue and is possibly due to the reduced size of Lshoff/off tissue (Fig.3.6A) 
forcing the same number of neurons to be in a smaller space (Fig. 4.2E).The g-ratio of a 
myelinated axon is the ratio of axon area excluding myelin to that including it. It is used as an 
index of to what extent myelination of a neuron performs its function of insulating the 
electrical signals sent through the fibre (Chomiak and Hu 2009). If LSH functions in OL 
survival alone, or there is a truly variegated phenotype where some OLs myelinate normally, 
and others don’t, you may expect for this g-ratio to be maintained in those axons that do 
receive myelination in Lshoff/off. To see if this is the case, I measured g-ratios from 275 
myelinated axons in Lshoff/off and Lsh+/off optic nerve and spinal cord, to consider a range of 
axon diameters. In both conditions, Lshoff/off neurons had a consistently lower g-ratio (Fig, 
4.2F). To see if this was consistent across all fibre diameters, I plotted g-ratio against axon 
area for the 275 neurons. The trend of high g-ratio in Lshoff/off holds across tissue and 






Figure 4-2 Axon calibre increases percentage myelinated axons and myelin thickness for axons Lshoff/off, 
though is still reduced in both criterions compared to Lsh+/off at P90 
A) Size stratified mean percentage myelinated axons in a sample of 200 axons across 3 animals per 
genotype in optic nerve. 
B) Size stratified mean percentage myelinated axons in a sample of 200 axons across 3 animals per 
genotype in spinal cord. Error bars represent SEM in A and B, P-values calculated by 2-way ANOVA 
and shown for the axon area factor for A and B. 
C) Bar chart showing numbers of axons across different calibre stratifications in the same optic nerve 
sample as A and B. 
D) Bar chart showing numbers of axons across different calibre stratifications in the same spinal cord 
sample as A and B. 
E) Average axon density across Lshoff genotypes and tissues, >1000 axons sampled per the 3 animals 
analysed., 
F) g-ratios across Lshoff genotypes and tissues, 275 axons samples across 3 animals per genotype 
G) g-ratios across Lshoff genotypes stratified by axon diameter, using the same sample as (F) for spinal 
cord. 
H) g-ratios across Lshoff genotypes stratified by axon diameter, using the same sample as (F) for optic 
nerve. 









4.3 Lshoff/off mice have an oligodendrocyte differentiation 
defect 
The experiments outlined above point to a cellular defect specific to the CNS rather than the 
production of myelin in general, that is not fully penetrate across all cells in a lineage, varies 
according to anatomical location, as well as varying greatly between animals. Large axons 
are still capable of stimulating OLs to myelinate, but even when they do, this is to a lesser 
extent than Lsh+/off .  The extent to which OLs myelinate axons often increases with maturity 
(Flores et al. 2008), indicating that those that can myelinate in Lshoff/off are still earlier in the 
differentiation process than Lsh+/off. Because of this and LSH’s previously characterised role 
in developmental gene regulation (Myant et al. 2011), I hypothesised that LSH is required to 
enhance OL differentiation, possibly from neural precursor cell (NPC) stage in the embryo 
and/or OPC stage postnatally. As LSH is canonically associated with the deposition of DNA 
methylation and a repressive chromatin environment (Muegge 2005), one possibility would 
be a failure to repress genes that inhibit progression through the OL lineage. Connections 
have also been made between LSH and the survival of NPCs in in vitro differentiation 
assays in another knock-out of the protein ((Han et al. 2017) and there is a decreased ability 
for cells to proliferate with a Lsh hypomorph mutation (Sun et al. 2004). Despite the fact we 
see near normal, or increased axon density in Lshoff/off, it remains possible that OLs, or other 
glial cells are affected by such a phenotype and either die or fail to proliferate and properly 
distribute throughout the CNS, causing the myelination defect. To distinguish between these 
possibilities, I set out to characterise the distribution and lineage progression of OLs 
throughout development. As the OL lineage has been extensively characterised in mouse, 
with distinct marker genes existing for different lineage stages (Fig.1.1) I decided to 





4.3.1 At post-natal day 14 there is a reduction of mature oligodendrocytes in the 
Lshoff/off optic nerve and an increase in oligodendrocyte precursor cell marker 
expressing cells 
Post-natal day 14 (P14) is a peak of developmental OL differentiation in mouse (Foran and 
Peterson 1992). As the lack of myelination in Lshoff/off is present throughout adulthood, I 
reasoned that if LSH indeed was required for the majority of OL differentiation during 
development, I would expect to see a decrease in lineage specific markers associate with 
differentiation at this timepoint. I also decided to look initially in optic nerve as it’s a pure 
white matter tract in the brain and so avoids complications that may arise from differences 
between white and grey matter OLs and previous experiments show it is hypomyelinated in 
Lshoff/off.  Due to large size differences between Lshoff/off and Lsh+/off optic nerves, I reasoned 
that the best way to assess the relative abundance of different lineage stages would be to 
count relative to the number of DAPI positive nuclei, as appose to area. Despite their 
decrease in optic nerve size, Lshoff/off animals retain a similar number of cells in optic nerve 
sections (Fig.4.3A, B). Staining of P14 optic nerve for the TF OLIG2, which is ubiquitously 
expressed throughout the OL lineage, reveals that Lshoff/off mice have a similar number of OL 
cells in the CNS (Fig.4.3A, C). Co-staining with QKI7 an RNA-binding protein specific for 
mOLs when present with OLIG2, reveals however that there is a decrease in the number of 
mOLs in Lshoff/off (Fig.4.3A, D). 
It’s possible that a similar number of OL lineage cells, but decrease in those expressing 
mature markers, is the result of OL lineage cells being unable to upregulate a specific 
mature marker, while normally expressing others. Therefor to investigate if this truly was a 
reduction in differentiated OLs, I performed similar staining, but using NG2, a marker or 
OPCs when co-staining with OLIG2. If OL lineage cells were unable to progress beyond the 
OPC stage of differentiation, I would expect to see an equivalent increase in NG2 positive 
cells to the decrease in QKI7 OLIG2 positive cells seen previously. Although there was a 
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statistically significant increase in NG2 OLIG2 cells of 30% in Lshoff/off this is lower in 
magnitude than the >40% decrease in OLIG2 QKI7 positive cells, in addition, the percentage 
of OLIG2 NG2 is lower than that of OLIG2 QKI7 in both genotypes (Fig. 4.3E, F). This result 
suggests that some OPCs are capable of downregulating OPC markers during development, 
but the proportion capable of progressing to the next stage in the lineage is reduced the 
closer they get to terminal differentiation to myelinating OLs. To investigate if this was in fact 
the case, I performed qPCR on reverse transcribed optic nerve mRNA from P14 optic 
nerves. The pattern of mRNA expression for OL differentiation genes differs somewhat from 
protein expression (Fig.4.3G). Lshoff/off optic nerves show a robust under expression of 
mature stage differentiation markers, consistent with immunofluorescence experiments, 
however OPC markers are not all consistently over expressed (Fig. 4.3H). This supports the 
idea that most OL lineage cells can repress OPC genes during differentiation in Lshoff/off and 




Figure 4-3 There is a reduction in mature oligodendrocytes and increase in OPC numbers in Lshoff/off P14 
optic nerve 
A) Representative images of DAPI, OLIG2 and QKI7 staining of Lsh+/off and Lshoff/off P14 optic nerve. 
B) Average number of cells in section imaged between genotypes. 
C) Percentage of DAPI positive cells also staining for OLIG2 between genotypes 
D) Percentage of DAPI positive cells also staining for OLIG2 and QKI7 between genotypes 
E) Representative images of DAPI, OLIG2 and NG2 staining of Lsh+/off and Lshoff/off P14 optic nerve. 
F) Percentage of DAPI positive cells also staining for OLIG2 and QKI7 between genotypes 
G) Schematic of gene expression in oligodendrocyte lineage progression 
H) qPCR of P14 optic nerve cDNA for myelin associated genes. 
Error bars on all samples represent standard deviation, unpaired t-tests using Welch’s correction 
were used for p-value calculation. *=P<0.05, **=P<0.005. n=3 animals/genotypes for A-F with 4 








4.3.2 The differentiation defect seen at P14 in Lshoff/off persists and is exacerbated 
at P90. 
At the P90 stage we see extensive hypomyelination of the CNS, however it is still possible 
that the differentiation defect seen at P14 is the result in a delay of OL differentiation, that 
could correct itself later in development. In this case, the cause of the myelin phenotype 
would be separate from the ability to regulate gene expression during differentiation e.g. 
once differentiated OLs are still unable to wrap axons. To test if this was the case, I 
performed similar cell marker comparisons between genotypes at P90 as to at P14. Total 
cell numbers and OLIG2 positive cell percentage at P90 are again similar between 
genotypes (Fig.4.4A, B,C). The reduction in OLIG2 QKI7 double positive cells is exacerbated 
on aging to P90 (Fig.4.4A, D). NG2 OLIG2 at P90 staining however reveals a larger increase 
in NG2 OLIG2 positive cells in Lshoff/off than at P14, but still proportionally smaller than the 
decrease in OLIG2 QKI7 positive cells (Fig.4.4E, F). qPCR of reverse transcribed P90 
mRNA is also consistent with immunofluorescence and P14 experiments (Fig4.4G). Taken 
together, this data shows that the failure to upregulate myelination and differentiation genes 
is persistent throughout development. 
  
Figure 4-4 There is a reduction in mature oligodendrocytes and increase in OPC numbers in the P90 
Lshoff/off optic nerve 
A) Representative images of DAPI, OLIG2 and QKI7 staining of Lsh+/off and Lshoff/off P90 optic nerve. 
B) Average number of cells in section imaged between genotypes. 
C) Percentage of DAPI positive cells also staining for OLIG2 between genotypes 
D) Percentage of DAPI positive cells also staining for OLIG2 and QKI7 between genotypes 
E) Representative images of DAPI, OLIG2 and NG2 staining of Lsh+/off and Lshoff/off P90 optic nerve. 
F) Percentage of DAPI positive cells also staining for OLIG2 and QKI7 between genotypes 
G) qPCR of P90 optic nerve cDNA for myelin associated genes. 
Error bars on all samples represent standard deviation, unpaired t-tests using Welch’s correction 
were used for p-value calculation. *=P<0.05, **=P<0.005, ***=P<0.0005. n=3 animals/genotype for 









4.3.3 Spinal cord oligodendrocytes progress further in differentiation than optic 
nerve, but still fail to terminally differentiate to myelinating oligodendrocytes 
 As a less severe defect was seen in percentage myelinated axons in P90 spinal cord 
compared to optic nerve, I hypothesised that Lshoff/off spinal cord OLs would be able to 
progress, on average, to a later stage of differentiation than those in optic nerve. To test this, 
I performed OLIG2 and QKI7 staining in spinal cord of P90 Lsh+/off and Lshoff/off animals.  Cell 
numbers and OLIG2 positive cell percentage again remain similar between genotypes 
(Fig4.5A, B, C) but strikingly, the percentage of OLIG2 QKI7 positive cells, largely due to 1 
animal, showed a tendency to increase in Lshoff/off (Fig.4.5A, D). As newly formed OLs 
express QKI7 higher than long matured OLs (Y. Chen et al. 2007), it’s possible this is the 
result of Lshoff/off spinal cord being in a still earlier stage of OL differentiation than Lsh+/off 
however still able to progress beyond the stage optic nerve OL lineage cells can. As the 
counts for the immunofluorescence was highly variable in the animals stained, I performed 
qPCR on reverse transcribed mRNA from spinal cord white matter from Lsh+/off and Lshoff/off 
to see if expression marker genes in mRNA were consistent with the protein data. Under 
expression of only Mag was detectable with other late stage marker genes unchanged 
(Fig4.5E). Olig2 is also the only gene expressed higher in OPCs that as overexpressed, as it 
is in P90 optic nerve. This is consistent with the idea that a less severe OL defect exists in 
the spinal cord than optic nerve of Lshoff/off, in concordance with the TEM data looking at 
myelin. 
Figure 4-5 There is no reduction in mature oligodendrocytes in the P90 Lshoff/off spinal cord, though some 
gene expression changes are present at the mRNA level 
A) Representative images of DAPI, OLIG2 and QKI7 staining of Lsh+/off and Lshoff/off P90 spinal cord. 
B) Average number of cells in section imaged between genotypes. 
C) Percentage of DAPI positive cells also staining for OLIG2 between genotypes 
D) Percentage of DAPI positive cells also staining for OLIG2 and QKI7 between genotypes 
E) qPCR of P90 spinal cord cDNA for myelin associated genes. 
Error bars on all samples represent standard deviation, unpaired t-tests using Welch’s correction 
were used for p-value calculation. *=P<0.05, **=P<0.005, ***=P<0.0005. n=3 animals/genotypes for 









4.4 Summary  
TEM confirms the hypothesis based on mouse phenotype and tissue observations that 
Lshoff/off CNS is exclusively hypomyelinated. This hypomyelination is present throughout all 
axon calibres in the CNS, though increased frequency and thickness of myelination suggests 
ability to respond to axonal signalling is intact in Lshoff/off. Marker gene expression analysis 
shows a robust reduction of mOLs in optic nerve throughout development, accompanied by 
a more modest increase in OPCs. This points to LSH deficiency causing an OL 
differentiation defect, but it remains unclear whether this is the result of extrinsic factors or is 
intrinsic to OPC gene regulation. To address this question and aim 2) of the project, I will 
exploit the conditionally reversible LSH system to see if LSH is required in OPCs and when 




5. Results- Chapter Five- The Lshoff/off 
myelination defect is cell autonomous to 
OPCs in the CNS, and LSH expression is 
only required early in life 
5.1 Introduction 
TEM analysis of myelin structure and marker gene expression profiling support that the 
myelin phenotype is indeed caused by a defect in OL differentiation. Myelin is reduced in all 
CNS tissues and developmental timepoints analysed A similar number of OLIG2 positive 
cells being present in Lshoff/off tissue to Lsh+/off suggests that this defect occurs in the OPC to 
mOL transition. OPC markers are upregulated and mOL (markers are reduced in all tissues 
and developmental timepoints analysed, albeit inconsistently in certain marker genes. The 
lesser extent and consistency of OPC marker gene over-expression compared to mature 
markers suggests the stage at which the majority Lshoff/off OL lineage cells arrest is 
intermediate between OPC and myelinating cells. Inhibitors of differentiation such as Id2 and 
Hes1 show no change in Lshoff/off, suggesting the initial hypothesis of failure to silence these 
factors in Lshoff/off being the cause of the phenotype is not the case. It is possible that this 
differentiation defect is the result of abolition LSH expression within OL lineage cells 
preventing proper regulation of crucial genes to lineage progression. However, greater 
severity of the phenotype in optic compared to spinal cord could also be evidence that tissue 
specific environment can overcome the differentiation block to an extent. An alternative 
explanation is intrinsic differences in spinal cord and optic nerve OLs, which has been 
studied extensively (Richardson et al. 2006), lead to differing requirements for differentiation, 
and that LSH is more essential for the implementation of the optic nerve OPC requirements 
than spinal cord. To test if the Lshoff/off phenotype is indeed cell autonomous to the OL 
lineage, I decided to exploit the conditionally reversable nature of the Lshoff allele and 
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characterise a mouse strain where Lshoff/off  was converted to Lshon/on specifically in OLs by 
breeding into a line where CRE recombinase is expressed under the control of a Pdgrα 
promoter, which is expressed exclusively in OPCs in the CNS (Sim et al. 2011). 
5.2 Conversion to Lshon/on in OPCs rescues the Lshoff/off 
myelination phenotype 
5.2.1 Lshoff/off; Pdgfrα-Cre animals do not develop ataxia or tremors in adulthood 
The loxP and lox411 sites of the Lshoff allele are orientated such that CRE expression and 
nuclear localisation causes an inversion of the SAGFPneoPA cassette. The splice acceptor 
can then no longer be recognised and full-length protein LSH is produced (Fig.5.1A). FLPo 
mediated conversion and expression rescue is shown in Fig.1.2 and ER-CRE mediated 
rescue of expression on tamoxifen treatment (experiment performed by Natalia Torrea). To 
see if this Cre mediated conversion of the Lshoff allele in PDGFRα expressing cells caused 
any detectable change in embryonic lethality compared to Lshoff/off I analysed the litter sizes 
from crosses of Lsh+/off; Pdgfrα-Cre × Lsh+/off. Litters of comparable size to Lsh+/off × Lsh+/off 
and Lsh+/off × Lsh+/+ are produced (Fig.5.1B). If the cellular defect responsible for the low 
levels of perinatal lethality seen in our Lshoff line is within PDGFRα expressing cells, I would 
expect to see an over representation of Lshoff/off; Pdgfrα-Cre animals resulting from 
Lsh+/off;Pdgfrα-Cre × Lsh+/off crosses, and a reduced proportion of animals making it to 
weaning.  There is no the significant decrease in proportion of mice weaned seen in Lsh+/off × 
Lsh+/+ in Lsh+/off;Pdgfrα-Cre × Lsh+/off showing there is not a detectable increase in embryonic 
lethality (Fig. 5.1C). The proportion weaned is also not significantly different from Lsh+/off × 
Lsh+/off, which does show reduced size compared to Lsh+/off × Lsh+/+, suggesting there may 
be a small intermediate perinatal lethality phenotype in the Lshoff/off;Pdgfrα-Cre line. 
However, as shown in chapter 3 genetic background can impact this phenotype in Lshoff 
lines and it should be noted that the lack of detectable lethality may be due to the fewer 
number of litters analysed (n=120 vs n=43 respectively). The mendelian ratio of genotypes 
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produced also does not differ significantly from those expected by chance in Lsh+/off;Pdgfrα-
Cre × Lsh+/off crosses as it does in Lsh+/off × Lsh+/off, again reduced n-number may render a 
difference undetectable. An important observation however is that Lshoff/off; Pdgfrα-Cre is not 
enriched in litters above that of Lshoff/off and if anything is decreased (Fig. 5.1D).  This 
indicates that conversion to Lshon/on in OPCs in the CNS and other cells outside of the CNS 
does not rescue the perinatal lethality associated with Lshoff/off. I next decided to test if the 
post-weaning growth defect seen in Lshoff/off is rescuable in Lshoff/off; Pdgfrα-Cre. Though the 
phenotype is which is less apparent in this genetic background, indicated by a less drastic 
difference between Lshoff/off animals and Lsh+/off litter mates seen in both males and females 
that in the Lshoff line not possessing Pdgfrα-Cre, there is a tendency for reduced weight 
compared to Lsh+/off;Pdgfrα-Cre that is not completely rescued in Lshoff/off (Fig. 5.1E, F).  If a 
lack of LSH specifically in OL lineage cells is responsible for the developmental lack of 
myelin in the Lshoff/off CNS, and this in turn is responsible for neurological phenotype in 
Lshoff/off mice, I would expect rescue of the phenotype in Lshoff/off; Pdgfrα-Cre. To test this I 
analysed blind scoring of littermate matched Lshoff/off;Pdgfrα-Cre, Lshoff/off and Lsh+/off;Pdgfrα-
Cre (control) animals. Lshoff/off; Pdgfrα-Cre do not possess a comparable neurological 
phenotype to Lshoff/off post weaning, though some animals scored for mild ataxia immediately 







5.2.2 Lshoff/off;Pdgfrα-Cre leads to conversion from Lshoff to Lshon specifically in 
oligodendrocyte lineage cells. OPCs derived from Lshoff/off animals however 
cannot be cultured using standard conditions 
To support the conclusion of the neurological phenotype analysis that OL lineage specific 
rescue of LSH expression from the OPC stage in development rescues the myelin 
phenotype, I sought to verify that conversion from the Lshoff to Lshon was occurring in OPCs 
specifically in Lshoff/off;Pdgfrα-Cre. To do this, I isolated OPCs from P7 mouse brain using a 
well-established adaptation of an immunopanning protocol. To verify that this protocol does 
indeed lead to a separation of specifically OPCs, and to investigate the purity of this 
population, I performed immunostaining on the OPC fraction of this isolation plated onto 
coverslips for Lsh+/+ animals. This revealed that 88% ± 2% of cells isolated were positive for 
the OPC specific marker NG2 (Fig.5.2A), with the remaining cells looking from DAPI staining 
as if they were dead. Isolation of gDNA from the OPC, whole brain homogenate and the 
OPC depleted fraction in this protocol (what remains following positive selection) in 
Lshoff/off;Pdgfrα-Cre followed by allele specific PCR amplification (Fig.5.2B) reveals 
conversion to Lshon specifically in OPCs (Fig.5.2C).  
Figure 5-1 Cre mediated conversion to Lshon in the oligodendrocyte lineage rescues neurological 
phenotypes of Lshoff/off 
A) Schematic representation of the timing of Lsh allele conversion in the Pdgfrα-Cre line (off to on) 
B) Boxplots showing litter sizes from Lshoff and Lshoff; Pdgfrα-Cre crosses. P-values result on unpaired 
t-test comparisons of conditions. Whiskers representative of upper and lower quartiles, n=39, 120 
and 43 respectively. 
C) Boxplots showing percentages of mice born in Lshon and Lshoff; Pdgfrα-Cre crosses. P-values the 
result of Mann-Whitney non-parametric tests due to non-normal distribution present in samples. 
Bounds of boxes represent minimum and maximum values, n numbers as with (B). 
D) Observed and expected rations of mice born from Lsh+/off; Pdgfrα-Cre × Lsh+/off crosses.P-values on 
graph the result of Chi-squared test comparing expected vs observed numbers. 
E) Line graph of mean weights post-weaning for males of Lsh+/off; Pdgfrα-Cre, Lshoff/off; Pdgfrα-Cre and 
Lshof/offf genotypes. Error bars show standard deviation, maximum n numbers=10, 12, and 7 
respectively, though this varies between timepoints due to culling and deaths. 
F) Line graph of mean weights post-weaning for females of Lsh+/off; Pdgfrα-Cre, Lshoff/off; Pdgfrα-Cre 
genotypes. Error bars show standard deviation, maximum n numbers=22, 15, and 17 respectively 
though this varies between timepoints for the first 2 genotypes due to culling and deaths. 
G) Scatter plot of neurological score for Lsh+/off; Pdgfrα-Cre, Lshoff/off; Pdgfrα-Cre genotypes, maximum 
n=32, 27 and 24 respectively though this varies between timepoints for the first 3 genotypes due to 





The gold standard for evidence that the differentiation defect is autonomous to OL lineage 
cells would be to remove OPCs from their in vivo environment and test the ability for Lshoff/off 
cells to differentiate. To attempt this, I isolated cells from Lsh+/off and Lshoff/off and attempted 
to expand them under well-established culture conditions(Emery and Dugas 2013). It was 
quickly apparent, on multiple attempts, Lshoff/off OPCs could not survive in culture long 
enough for analysis of differentiation (Fig.5.2D). This provides evidence that the in vivo 
environment of Lshoff/off OPCs confers a greater compacity to support OPCs than that in vitro. 
It is also possible that the growth factors supplemented to OPCs in culture force Lshoff/off to 
divide more than they have an ability to do so, and thus leads to cell death. However, as this 
doesn’t seem to be the case in vivo, due to the similar number of OLIG2 positive cells 
observed between genotypes, rather than speculate further I focused efforts n 
characterisation of the in vivo phenotype of Lshoff/off;Pdgfrα-Cre. 
  
Figure 5-2  Lshoff/off;Pdgfrα-Cre leads to specific conversion to Lshon/on in OPCs 
A) Representative image of DAPI and NG2 staining in isolated OPCs, n=3 isolations using different 
animals. 
B) Schematic explaining expected PCR products from different SAGFPneoPA cassette orientation in 
LshGFPneo animals. 
C) Image of agarose gel running allele specific PCR products across OPC isolation fractions in rescue 
and control genotypes. 









5.2.3 Adult Lshoff/off; Pdgfrα-Cre animals are myelinated grossly normally and do 
not have an oligodendrocyte differentiation defect 
To see if and to what extent OL lineage specific rescue of LSH expression rescues the 
myelination in Lshoff/off I performed TEM on axons from the most severely affected tissue in 
Lshoff/off, optic nerve. It was immediately apparent that Lshoff/off;Pdgfrα-Cre possessed no 
apparent myelin phenotype whereas Lshoff/off littermates were severely hypomyelinated 
(Fig.5.3A). This supports the conclusion of the neurological scoring analysis, that conversion 
to Lshon in the OL lineage rescues the myelin phenotype and the presumption that 
neurological phenotype was the result of lack of myelin. To see if rescue in myelination was 
accompanied by rescue of OL differentiation, I performed a similar analysis of stage specific 
OL lineage marker genes as I had done for Lshoff/off animals in chapter 4. DAPI positive cells 
numbers in adult optic nerves taken at P90 to P120 were consistent between all genotypes 
(Fig. 5.3B, C). Lshoff/off;Pdgfrα-Cre does show an increase in OLIG2 positive cells compared 
to other genotypes (Fig. 5.3B, D). OLIG2 and QKI7 staining shows a complete rescue in 
mOL numbers in Lshoff/off;Pdgfrα-Cre to the level of Lsh+/off;Pdgfrα-Cre controls and a 
reduction in Lshoff/off littermate controls comparable to that seen in non-Pdgfrα-Cre 
possessing line (Fig5.3B, E). qPCR of OL stage specific marker genes also shows 
comparable levels of expression in Lshoff/off;Pdgfrα-Cre to Lsh+/off;Pdgfrα-Cre, with maybe a 
decrease in mOL genes, though to a smaller extent than in Lshoff/off (Fig. 4.4) (Fig.5.3F). 
Taken together, these data rule out rescue being a consequence of breeding Lshoff into a 
different genetic background. The rescue is also to an extent that wild-type-like numbers of 
mature of OLs were detectable, ruling out other CNS cell-types as exacerbating factors in 







5.3 Conversion to Lshoff/off specifically in OPCs causes no 
neurological phenotype 
The Pdgfrα driven CRE converts Lshoff to Lshon in OPCs, which arise at E12.5 (Pringle and 
Richardson 1993) and the allele remains converted from then on in development. The 
possibilities that LSH is required prior to differentiation to mOL or during the differentiation, 
remain indistinguishable by the experiments performed so far. In order to distinguish 
between these possibilities, and further narrow down a cellular cause for the Lshoff/off 
myelination phenotype, I again descended to exploit the conditionally reversible knock-out 
system. Crossing of Lshon/on animals where the Lshoff allele was converted using the FLPo 
recombinase in previous generations, into the Pdgfrα-Cre possessing line, results in mice 
that specifically convert to Lshoff2 in OLs in the CNS. As the half-life of LSH protein in OPCs 
is unknown, some remaining LSH in the OL lineage cells of these animals can’t be ruled out, 
but this would be further diluted in an individual cell through division following conversion  
If LSH is required during differentiation from OPCs to mOLs therefor, I reasoned that these 
OPC conditional knock-out animals may still possess a myelination phenotype, albeit it 
milder than in Lshoff/off due to the remaining LSH protein. In contrast if LSH was required 
exclusively early in development then I would expect Lshon/on;Pdgfrα-Cre animals would 
show no myelin phenotype. The Lshoff/off;Pdgfrα-Cre experiment has suggested there are 
Figure 5-3 Cre mediated conversion to Lshon in the oligodendrocyte lineage rescues the cellular 
phenotype of Lshoff/off 
A) Representative TEM images of myelin in P90 Lsh+/off;Pdgfrα-Cre, Lshoff/off; Pdgfrα-Cre and Lshoff/off 
littermate optic nerves. 
B) Representative images of DAPI, OLIG2 and QKI7 staining of Lsh+/off;Pdgfrα-Cre, Lshoff/off; Pdgfrα-Cre 
and Lshoff/off P90 optic nerves. 
C) Average number of cells in section imaged between genotypes. 
D) Percentage of DAPI positive cells also staining for OLIG2 between genotypes. 
E) Percentage of DAPI positive cells also staining for OLIG2 and QKI7 between genotypes. 
F) qPCR of P90 optic nerve cDNA for myelin associated genes. 
Error bars on all samples represent standard deviation, unpaired t-tests using Welch’s correction 
were used for p-value calculation. *=P<0.05. n=3 animals/genotypes for A-F with 4 sections counted 





also phenotypes that are not linked to OPC LSH expression, such as body weight, I would 
expect animals that are Lshon/on in all tissue but OPCs not be subject to these. To address 
these possibilities and support the conclusions of the rescue experiment, I therefore set out 
to characterise phenotype of Lshon/on;Pdgfrα-Cre animals. 
5.3.1 Lshon/on; Pdgfrα-Cre animals are born at a normal mendelian ratio and have no 
detectable phenotype 
In Lshon/on;Pdgfrα-Cre Lshon is in theory converted to Lshoff specifically in the OL lineage from 
E12.5 (Fig.5.5A). To test if this is the case at the genetic level, I performed an allele specific 
PCR on gDNA isolated from Lshon/on;Pdgfrα-Cre and Lshon/on  optic nerve, which are enriched 
for OL lineage cells and ear tissue, which also expresses PDGFRα in the majority of cells at 
some point during development (Andrae et al. 2014). Lshoff is present to a much higher level 
in both tissues in Lshon/on;Pdgfrα-Cre, and completely absent in Lshon/on (Fig. 5.5B). 
Characterisation of the Lshon/on;Pdgfrα-Cre phenotype requires a comparison to animals in 
the same genetic background which would not be expected to possess any phenotype. As 
Lsh+/off animals have no detectable phenotype, and these animals have a single Lshoff allele 
in PDGFRα expressing cells. I reasoned that the use of Lshon/+;Pdgfrα-Cre animals would fit 
this requirement as they would also be heterozygous Lshoff in OPCs, but express LSH to 
wild-type levels in other cell types, as would Lshon/on;Pdgfrα-Cre. 
Lshon/on animals are fertile but show a reduction in litter sizes in comparison to Lsh+/off X 
Lsh+/+ crosses and outcrossing of the Lsh lines has previously been shown to influence 
perinatal lethality (Fig. 3.3). If these phenotypes are solely the result of outcrossing Lsh lines 
and not the specific alleles there possess, they may be apparent in Lshon/on;Pdgfrα-Cre and 
be a potential confounding factor is connecting phenotype to OPC specific knock-out. To test 
if any embryonic lethality is associated with PDGFRα expressing cell specific deletion of 
LSH or if the fertility phenotype seen in Lshon/on is still present on outcrossing the Lshon line to 
Pdgfrα-Cre I analysed litter sizes in Lshon/+;Pdgfrα-Cre × Lshon/on crosses. There is no 
95 
 
detectable reduction in litter sizes compared to Lsh+/off × Lsh+/+ and increase compared to 
Lshon/on × Lshon/on and Lsh+/off × Lsh+/off (Fig. 5.5C). In addition I analysed the proportion of 
Lshon/+;Pdgfrα-Cre × Lshon/on litters making it to weaning, and this is unchanged compared to 
other genotypes (Fig.5.5D). Lshon/on; Pdgfrα-Cre mice were also born to the expected 
Mendelian ratio (Fig. 5.5E) and do not possess a growth phenotype in male or females 
(Fig.5.5F, G). In addition, Lshon/on; Pdgfrα-Cre animals do not possess a neurological 







Figure 5-4 OPC specific knock-out has no detectable breeding or growth phenotype 
A) Schematic representation of the timing of Lsh allele conversion in the Pdgfrα-Cre line (on to off) 
B) Image of agarose gel running allele specific PCR products across OPC isolation fractions in knock-
out and control genotypes. 
C) Boxplots showing litter sizes from Lshoff, Lshon and Lshon; Pdgfrα-Cre crosses. P-values result on 
unpaired t-test comparisons of conditions. Whiskers representative of upper and lower quartiles, 
n=39, 12, 34 and 15 respectively. 
D) Boxplots showing percentages of mice born in Lshoff, Lshon and Lshon; Pdgfrα-Cre crosses. P-values 
the result of Mann-Whitney non-parametric tests due to non-normal distribution present in samples. 
Bounds of boxes represent minimum and maximum values, n numbers as with (B). 
E) Observed and expected rations of mice born from Lsh+/on; Pdgfrα-Cre × Lshon/on crosses. P-values 
on graph the result of Chi-squared test comparing expected vs observed numbers. 
F) Line graph of mean weights post-weaning for males of Lsh+/on; Pdgfrα-Cre × Lshon/on; Pdgfrα-Cre 
genotypes. Error bars show standard deviation, n=4 and 6 respectively. 
G) Line graph of mean weights post-weaning for females of Lsh+/off; Pdgfrα-Cre, Lshoff/off; Pdgfrα-Cre 








5.3.2 Lshon/on; Pdgfrα-Cre animals are myelinated grosely normally and do not have 
an oligodendrocyte differentiation defect 
As mentioned earlier, the lack of a growth phenotype was expected in Lshon/on;Pdgfrα-Cre 
due to Lshon/on being present in non-PDGFRα expressing cells and the persistence of a mild 
growth phenotype in Lshoff/off;Pdgfrα-Cre suggesting that these cells were at least not entirely 
responsible for reduced weight. The perinatal phenotype not being present may be due to 
the susceptibility of the small effect seen in Lshoff/off to be altered due to outbreeding of the 
strain. However, the non-statistically significant tendency for Lsh+/off;Pdgfrα-Cre × Lsh+/off to 
have a reduced proportion of animals reaching weaning is not present in Lsh+/on;Pdgfrα-Cre 
× Lshon/on, which more closely resembles Lsh+/off × Lsh+/+ crosses. This suggests again that 
this phenotype is caused by the lack of LSH expression in non PDGFRα expressing cells.  
The lack of observable neurological phenotype in Lshon/on;Pdgfrα-Cre when mice were aged 
up until 1 year,  suggests that also no myelin phenotype is present. It is conceivable that 
OPC specific knock-out of LSH could still confer an OL differentiation defect, albeit to a 
much lesser extent than seen in Lshoff/off.  One might even expect this scenario to be the 
case if small amounts of LSH remain in OL lineage cells due to lack of degradation following 
expression being abolished at E12.5. Therefor to see if any evidence of myelination or OL 
differentiation defect could be found at the molecular level and test the hypothesis that LSH 
is not required in the OPC to mOL differentiation to any extent, I performed characterisation 
of OL stage specific marker gene expression in P120-P200 Lshon/on; Pdgfrα-Cre animals. 
TEM analysis of myelin in the optic nerve of 3 individuals of Lshon/on;Pdgfrα-Cre and 
Lshon/+;Pdgfrα-Cre revealed no obvious signs of reduced myelin thickness or coverage (Fig. 
5.6A).  DAPI and immunostaining for OLIG2 reveal similar total cell numbers and OL lineage 
cell numbers in Lshon/on;Pdgfrα-Cre and Lshon/+;Pdgfrα-Cre (Fig.5.6B, C, D). The percentage 
of mOLs staining for OLIG2 and QKI7 also remains the same between genotypes (Fig. 19B, 
E). Finally qPCR of reverse transcribed optic nerve mRNA for OL stage specific marker 
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Figure 5-5 Cre mediated conversion to Lshoff in the oligodendrocyte lineage does not lead to the cellular 
phenotype observed in Lshoff/off 
A) Representative TEM images of myelin in P90 Lsh+/on;Pdgfrα-Cre, Lshon/on; Pdgfrα-Cre littermate optic 
nerves. 
B) Representative images of DAPI, OLIG2 and QKI7 staining of Lsh+/on;Pdgfrα-Cre, Lshon/on; Pdgfrα-Cre 
P90 optic nerves. 
C) Average number of cells in section imaged between genotypes. 
D) Percentage of DAPI positive cells also staining for OLIG2 between genotypes. 
E) Percentage of DAPI positive cells also staining for OLIG2 and QKI7 between genotypes. 
F) qPCR of P90 optic nerve cDNA for myelin associated genes. 
Error bars on all samples represent standard deviation, unpaired t-tests using Welch’s correction 
were used for p-value calculation. *=P<0.05. n=3 animals/genotypes for A-F with 4 sections counted 









The Lshoff/off defect in OL differentiation is rescued on early life expression of LSH in OPCs, 
with a partial growth phenotype possibly still remaining. This strongly suggests that the OL 
differentiation defect is cell autonomous to OPCs. However somewhat counter to my initial 
expectations when initially proposing the OPC specific knock-out experiment, these data 
support that LSH is not required in the OL lineage for differentiation, at least when this 
knock-out occurs later than an undefined but relatively early period after E12.5 in 
development. This would rule out expression being required during OPC to mOL 
differentiation. But it does not rule out that conversion achieved in Lshoff/off;Pdgfrα-Cre 
enables the crucial function in OL differentiation to occur in development, but later than it 
usually would in a wildtype situation. While further experiments into the precise timing of 
LSH requirement in OL development would potentially shed light on LSH’s molecular 
function, the evidence in this chapter supports some LSH requirement in OPCs prior to 
differentiation.  
A major problem in studying the molecular mechanism of LSH deficiency in OL 
differentiation is distinguishing between the primary effects of LSH on transcription, that may 
be causal in the phenotype, and secondary transcriptional changes that are the result of 
failed OL differentiation. I now know the defect occurs within OPCs, and not following their 
initiation of differentiation to OLs. Therefore, presumably, primary effects of the LSH 
deficiency will be present, but secondary effects of failure of Lshoff/off OPCs to differentiate 
will be absent. 
To test the hypothesis that LSH’s function in regulation of chromatin state is causal in the OL 
differentiation defect, I will need to compare chromatin state in undifferentiated OPCs, prior 
to the accumulation of secondary effects, but where primary effects of LSH deficiency are 
presumably still detectable. 
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6. Results- Chapter Six- LSH is required for 
activation of late stage oligodendrocyte 
genes, but genome-wide methylation 
patterns in OPCs are largely unchanged 
 
6.1 Lshoff/off mice can silence inhibitors of oligodendrocyte 
differentiation but do not effectively silence non-CNS 
genes and fail to upregulate genes involved in crucial 
to myelination 
6.1.1 Introduction 
Rescue of LSH expression in OPCs results in rescue of the myelin phenotype, indicating that 
it is cell autonomous to OPCs. However, the Pdgfrα promoter is active in the gut and other 
organ systems that may have a organism wide effect on phenotype (Andrae et al. 2014). As 
no culture or differentiation of Lshoff/off OPCs can be carried out removing them from their in 
vivo environment, a potential role for these systems in the Lshoff/off myelin phenotype cannot 
be ruled out. Perturbation of these systems would cause effects in other cell types in addition 
to OLs, therefor I would expect analysis of expression changes in Lshoff/off compared to 
Lsh+/off to reveal major changes in genes expressed in non-OL CNS cell types. 
In addition, previous analyses of marker gene expression do not consider the entirety of 
relevant gene expression for the OL lineage, and despite not being consistent with the data 
so far, it remains possible that genes known to be inhibitors differentiation are the causal 
factors in preventing Lshoff/off differentiation. It also remains possible, as marker gene 
expression profiling so far suggests, that expression of key genes required for differentiation 
to progress and are unable to be upregulated in the absence of LSH. 
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To see if any evidence can be gathered supporting either de-repression of inhibitors of 
differentiation, or repression of genes required for progress in differentiation, and to see if 
other CNS cell types show a perturbation in Lshoff/off, I decided to perform RNA-sequencing 
to interrogate relative transcript levels in Lsh+/off and Lshoff/off optic nerve. 
6.1.2 Lshoff/off optic nerves show no consistent change in expression of genes 
specific to CNS cell types, apart from those in the oligodendrocyte lineage 
To limit the influence of individual variation on differential expression calls in Lshoff/off and due 
to limitations in the amount of material that could be collected from optic nerve, I made 
sequencing libraries from 2 pools of 6 optic nerve pairs per genotype. Sequencing of these 
libraries revealed 566 genes significantly over-expressed greater than 2-fold and 312 genes 
under-expressed greater than 2-fold, with the principle component separating libraries 
explaining 76% of variation between them, and genotypes clustering on opposite sides of 
this component (Fig, 6.1A, B). The biased towards over-expression being consistent with 
LSH’s canonical role as a gene repressor. 
To shed light on whether these mis-expressed genes were associated with particular CNS 
cells types, I first needed to define a group of genes whose expression could be said to be 
specific to a particular cell type. To do this, we used the Barres RNA-seq database (Zhang et 
al. 2014).The assumption being that the majority of genes that are expressed highly in a 
specific cell type over all others, would reflect genes expressed highly by the cell type in in 
vivo. A factor confounding this assumption is the cell types of the Barres dataset have been 
subjected to the manipulations of in vitro culture. We reasoned that expression artefacts of 
this culture, such as high expression of cell cycle genes due to a maintained state of 
division, or cell death genes due to increased turnover of cells grown in vitro, would be 
largely common to multiple cell types and therefore not deemed specific by the analysis. 
Another confounding factor I predicted would be the possibility that specific sub-types of 
cells isolated and cultured would not be representative of the full diversity of expression 
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patterns in vivo. I reasoned that although bias towards the particular sub-type of cells 
sequenced in this data would be inevitable, the broad trends in cell type specific gene 
expression would be captured by the analysis and comparison to other datasets would be 
capable of corroborating its conclusions.  
To define the top 100 specific genes for each cell type genes were simply assigned a ratio 
for expression in RPMK in a given cell type to the mean of RPKM in all other cell types. They 
were then ranked by this ratio, and the top 100 considered specific. When the RPKM is 
plotted for these top 100 genes for each Barre’s cell type on the same axes as all other cell 
types, the degree of specificity of these genes to a cell type can be assessed (Fig. 6.2A, B, 
C, D, E, F, G). The highest expression of top 100 specific genes in other cell types was 
seen, predictably, among different stages of the OL lineage (Fig.6.2C, D, E). There was also 
some expression of the top 100 OPC specific genes within microglia (Fig 6.2F). This is 
consistent with the reported ~10% microglial contamination present in the Barres isolations 
(Zhang et al. 2014). Another noticeable pattern was that OPC specific genes seemed to 
have a much lower expression in RPKM than newly formed oligodendrocytes (NFOLs) and 
myelinating oligodendrocytes (MOLs), median RPKM 10.9, 26.9 and 29.1 respectively. This 
could partly explain when plotting transcript per million TPM values of each specific gene set 
in the Lsh+/off and Lshoff/off dataset reveals a higher level of expression for NFOL and MOL 
genes than OPC genes even in Lshoff/off where myelin is lacking (Fig.6.2H). When looking at 
a relative quantification of specific transcripts in each cell type between genotypes however 
it becomes apparent that there is only a directionally consistent change in expression for 
MOL and to a lesser extent NFOL specific genes, with median values being reduced 
compared to Lsh+/off (Fig.6.2I). There is also more of a mixture of under and over expressed 
transcripts for OPC specific genes and those for CNS cell types other than MOLs.  
Consistent with major changes in cell type specific gene expression only occurring in later 
stage OL lineage genes, analysis of the adjusted p-value for expression changes in genes 
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revealed most changes in non-MOL genes were not significant, while over 50% of genes 
assigned to be specific for MOLs were above p<0.05 threshold (Fig. 6.2J).  
Taken together this supports the hypothesis that upregulation of mOL genes are responsible 
for the Lshoff/off differentiation defect, and that cells are in fact able to effectively silence the 
major proportion of inhibitors of differentiation, or at least those that are specific to OPCs in 
relation to other CNS cell types. In addition, the lack of major consistent changes in specific 
gene sets for other CNS cell types, while not ruling out some perturbation of these cell types, 
suggests there isn’t a major scarcity or abundance of these cell types in the Lshoff/off CNS, 





Figure 6-1 There is widespread misexpression of genes in the Lshoff/off CNS, with a skew towards 
overexpression 
A) Volcano plot differential gene expression in Lshoff/off optic nerve as determined by RNA-seq. 566 
genes are significantly over-expressed greater than 2-fold and 312 genes are under-expressed 
greater than 2-fold, p-value defined as <0.05 FDR=0.01. 
B) Principle component analysis of the 4 analysed RNA-seq libraries. The greatest variation between 
samples is determined by genotype with opposite genotype libraries further from each other than 









6.1.3 Patterns in oligodendrocyte lineage stage specific gene expression are 
consistent across in vitro and in vivo datasets 
Comparison of genes mis-expressed in Lshoff/off optic nerve to those identified to be specific 
to CNS cell types in the Barres RNA-seq database supports previous experiments 
suggesting that mOL genes are under-expressed and OPC genes are not over-expressed to 
a similar extent. The artefacts of the in vitro isolation and culture performed in the Barres 
experiments to some extent reduces the relatability of conclusions reached about in vivo OL 
differentiation in Lshoff/off. In addition, the approach used to define specific sets of genes 
relies on comparison to non-OL CNS lineages. Commonalities in highly expressed genes 
within the whole OL lineage, regardless of differentiation stage, will therefore be excluded 
from any comparison despite possibly being expressed more highly at a particular stage of 
OL differentiation. There is also an uneven coverage across cell types for Barres defined 
specific genes in the optic nerve RNA-seq. MOL specific genes tend to produce in greater 
transcript numbers in the in vitro differentiated MOLs than OPC specific genes are 
expressed in OPC. This is likely also the case in vivo as TPM values for MOL specific genes 
are higher even in Lshoff/off optic nerve, despite the lack of myelin. Changes in expression of 
genes that are well covered are more likely to be detected by RNA-seq differential 
expression analysis, so a bias to detecting differences in MOL genes is a conceivable 
explanation for the patterns seen when comparing Lshoff/off fold changes to the Barres data. 
To further test the hypothesis that in Lshoff/off primarily mOL genes are mis-regulated in the 
Figure 6-2 Mature oligodendrocyte specific genes are robustly under-expressed in Lshoff/off but there is 
not extensive overexpression of OPC genes, or misexpression of genes associated with other CNS cell 
types 
A-G) Boxplots of expression of top 100 CNS cell type specific genes across CNS cell types.                         
H)  The mean expression of top 100 cell type specific genes in both genotypes in TPM.                                  
I) Boxplots of fold change in expression in Lshoff/off relative to Lsh+/off for top 100 cell type specific genes 
across CNS cell types.                                                                                                                                        
J) Boxplots showing adjusted p-value for top 100 cell type specific genes across CNS cell types. Lines 
represent median gene fold change with upper and lower box limits defining upper and lower quartiles, dots 





OL lineage, I therefor decided to perform comparisons on other publicly available data sets 
where stage specific gene expression information could be inferred. 
One such dataset is derived from microarray-based gene expression comparisons of rat OL 
lineage cells stimulated to differentiate in vitro at set timepoints following initiation of 
differentiation (Swiss et al. 2011). As rat OPCs can be cultured more readily in vitro than the 
mouse OPCs used in Barres’ experiments, the degree of microglial contamination is 
reduced.  Stage specificity is also defined purely based on comparisons within the OL 
lineage, enabling calling of genes expressed in other CNS cell types to a specific OL 
differentiation stage. When we plot the mouse homologues of the genes defined as 
characteristic of different timepoints in differentiation by this study, late stage genes most 
clearly show a trend for directional change in expression in Lshoff/off (Fig.6.3A). Over-
expression of a subset of early-stage downregulated genes, as well as genes that do not fit 
the general trend of later the timepoint can be detected. Deviations to from the general trend 
could be ascribed differences between in vitro culture vs in vivo differentiation or to 
differences between rat and mouse OPC differentiation. Another explanation for these could 
be the reduced transcript number in the optic nerve RNA-seq compared to the consistently 
under-expressed late stage OL genes that we see in the Barres comparison. When plotting 
the expression in Lsh+/off onto the stage specific genes, low expression genes over-
expressed in the early downregulated category, that would not be subject to coverage bias, 
are detectable (Fig.6.3B). This suggests coverage cannot fully explain the late stage OL 
specific effect seen in Lshoff/off. 
To attempt to address the confounding factors introduced by artefacts associated with in 
vitro differentiation, and those caused by species differences between rat and mouse, we 
also plotted the Lshoff/off optic nerve expression changes stratified according defined to be 
characteristic of different lineage stages, across organism development by single cell RNA 
sequencing of mouse tissue (Marques et al. 2016). Here a tree building approach to cell type 
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definition was used by the authors whereby cells within a stage of OL differentiation would 
be separated from others based on differences in gene expression. I reasoned that an 
advantage of this approach would be, due to limited coverage available in single-cell 
sequencing, that only the most highly expressed OPC genes, or those most specific to 
OPCs would characterise a lineage stage. When comparing genes which define the 
branches between OPCs, NFOLs and MOLs generically, we again see a consistent pattern 
of MOL and NFOL defining gene under-expression, and little overexpression of OPC 
defining genes (Fig.6.4A). In addition, when plotting the expression values for each defining 
gene set, we see that even relatively highly expressed OPC genes are not over-expressed in 
Lshoff/off (Fig.6.4B). The single cell analysis also defines different sub-types OLs within 
different stages of differentiation. When using the author’s definition for more specific OL 
sub-types, we see that under-expression in Lshoff/off optic nerve is most apparent in the 
MOL2 and MOL6 subtype, with MOL3 largely being unchanged (Fig. 6.4C). Interestingly, 
NFOL2 but not NFOL1 showed under-expression in Lshoff/off and myelin-forming 
oligodendrocyte-2 (MFOL2), but not MFOL1 genes shows under-expression. The fact that 
under-expression isn’t generic to all sub-types, hints at a specific class of genes in OL 
differentiation requiring LSH for upregulation. It is also consistent with the observation that 
some OLs progress further in differentiation than others in Lshoff/off, such as those in the 
spinal cord. However, more functional and anatomical characterisation of each OL sub-type 
is required to support these possibilities. It may be that the unchanged cell types are not 
present in adult optic nerves. In this scenario the fact that these potentially absent sub-types 
show no consistent under-expression in Lshoff/off acts as a negative control for e conclusions 




Figure 6-3  Comparison to other oligodendrocyte lineage stage specific gene expression datasets 
supports conclusion that primarily mature oligodendrocyte genes are mis-expressed 
A) Boxplots of fold change in Lshoff/off relative to Lsh+/off stratified by gene regulatory clusters defined by 
Swiss et al. Lines represent median gene fold change with upper and lower box limits defining upper 
and lower quartiles, dots are >2 standard deviations from the mean. 
B) Jitter plot of the same data as show in A colour coded by expression in Lsh+/off in TPM. Genes with 






Figure 6-4 Comparison of relative Lshoff/off gene expression of oligodendrocyte subtype defining genes 
from single cell  in vivo data sets reveals that not all oligodendrocyte subtypes under-express genes 
Lshoff/off 
A) Boxplots show log2 fold change in Lshoff/off relative to Lsh+/off stratified by oligodendrocyte stage 
defining genes derived from Marques et al.  
B) Jitter plot of the same data as show in A, colour coded by expression in Lsh+/off in TPM. Genes with 
low expression show less of a tendency to change than higher expressed mature oligodendrocyte 
genes. 
C) Boxplots show log2 fold change in Lshoff/off relative to Lsh+/off stratified by oligodendrocyte subtype 
defining genes derived from Marques et al. In A and C lines represent median gene fold change with 






6.1.4 Lshoff/off fails to upregulate genes involved in cholesterol biosynthesis 
Analysis so far supports conclusions from previous marker gene expression characterisation 
in Lshoff/off optic nerve that OL lineage cells arrest in differentiation to mOLs at some stage 
following OPC, but prior to the upregulation of mOL genes. However, not all mOL associated 
genes are mis-regulated in Lshoff/off. This leads me to the hypothesis that a specific process 
or processes required for the differentiation of mOLs is perturbed.  
To test these hypotheses, I performed gene ontology analysis on genes significantly under-
expressed in Lshoff/off optic nerve greater than 2-fold. Strikingly, genes involved in sterol and 
lipid biosynthesis were most significantly overrepresented amongst the under-expressed 
genes (Fig. 6.5A.). Cholesterol biosynthesis is a well-known pathway required for OL 
differentiation (Chrast et al. 2011). Recently, it has been discovered that Imidazole 
antifungal drugs and many known drugs used to enhance OL differentiation work 
exclusively through the regulation of production 8,9-unsaturated sterols, an intermediate 
in cholesterol biosynthesis, with accumulation of these sterols enhancing differentiation 
(Hubler et al. 2018). Analysis of specific genes required at the key steps of the sterol 
biosynthesis, defined by Hubler et al., identified a decrease in components upstream of 
synthesis of the 8-9-unsaturated sterols, with those downstream of lanosterol production 
also showing a decrease in expression, notably cyp51 with a 2.7-fold decrease (Fig. 
24B). Also, these genes are nearly all significantly differentially expressed between 
conditions to a high p-value (Fig. 6.5C). This suggests that accumulation of 8,9-
unsaturated sterols is prevented in Lshoff/off due to lack of upstream intermediates in their 
biosynthesis and supports that a lack of cholesterol synthesis, and not downstream 
metabolism of 8,9-unsaturated is responsible for a lack of differentiation. Whether this is 
a direct effect of LSH being unable to directly regulate these genes in Lshoff/off or a 
secondary effect caused by mis-regulation of other genes that then go on to effect sterol 








6.1.5 Lshoff/off primarily fails to silence genes involved in protein synthesis and those 
not normally expressed in optic nerve 
OPC and non-OL lineage CNS cell type specific genes are not over-expressed in Lshoff/off, 
but most significant expression changes in Lshoff/off are over-expressed compared to Lsh+/off. 
In previous Lsh knock-outs, there is significant over-expression of genes present in 
constitutive heterochromatin, such as intracisternal A-particle (IAP) retrotransposons, along 
with other repetitive elements (Muegge 2005). This leads to the hypothesis that the over-
expressed genes in Lshoff/off optic nerve are mainly composed of such elements and genes 
that are not expressed in Lsh+/off optic nerve. 
To test this, I performed similar gene ontology analysis as previously but including genes 
overexpressed greater than 2-fold reveals the most significantly over-represented 
processes are related to general protein synthesis (Fig. 6.6A). This is surprising given 
the obvious essential role for these proteins in all cell-types. In addition, the number of 
genes associated with a significant term were much lower for over-expressed genes 
compared to under-expressed despite more genes being over-expressed overall. I 
reasoned that if most genes being over-expressed in Lshoff/off are associated with 
heterochromatic regions in OLs, it might be expected that they are associated with 
disparate biological processes or are transposable elements that won’t be associated 
with a GO-term. To see if the former was the case, I plotted expression level in Lsh+/off as 
an indication of expression in a phenotypically normal optic nerve against log2 fold 
change in Lshoff/off. This reveals that indeed many overexpressed genes are expressed to 
a very low level in Lsh+/off despite low coverage making determination of significance for 
Figure 6-5 Cholesterol biosynthetic genes are almost uniformly under-expressed in Lshoff/off optic nerve 
A) Gene ontology analysis by G:profiler of under-expressed genes in Lshoff/off in comparison to Lsh+/off.  
B) Fold change in Lshoff/off relative to Lsh+/off transcripts for enzymes involved in sterol biosynthesis 
defined in Hubler et al. and the sterol regulatory element binding transcription factors Srebf1 and 
Srebf2. 






these genes more challenging (Fig. 6.6B). It is conversely not the case that genes 
expressed at low levels in Lshoff/off are over-expressed in Lsh+/off. To test if these genes 
included transposable elements, we plotted reads mapping to IAP features across 
libraries. This revealed there was a significant overexpression of these elements in 
Lshoff/off however fold changes are not comparable to even conditional gene knock-outs 
where IAP element repression is ablated (Fig.6.6C)(Ramesh et al. 2016). To see if any 
link between IAP overexpression and the severity of the OL differentiation phenotype 
was apparent, I performed qPCR on cDNA reverse transcribed from mRNA isolated from 
P14 optic nerve, P90 optic nerve and P90 spinal cord. I reasoned that if IAP 
overexpression prevented OL differentiation, I would expect to see a larger magnitude 
increase in optic nerve, where phenotype is more severe, than spinal cord, where OPCs 
can differentiation to a later stage. This was not the case, with comparable fold-changes 
between P90 tissues (Fig 6.6D). It is conceivable that the over-expression of translation 
associated genes is linked to the de-repression of repetitive elements in Lshoff/off, as 
expression of viral mRNA has previously been associated with modulation of 
translational machinery expression (Le Sage et al. 2016). Also, retroviral element 
overexpression may explain the over-representation of the anti-microbial humoral 
immune response (Chernyavskaya et al. 2017, Grow et al. 2015). The overexpression 
non-optic nerve associated genes, retroviral elements and the associated responses to 
this over expression could conceivably perturb OL differentiation. 
  
Figure 6-6 Overexpressed genes in Lshoff/off optic nerve are from divergent biological processes and 
generally expressed to a low level in Lsh+/off 
A) Gene ontology analysis by G:profiler of overexpressed genes in Lshoff/off in comparison to Lsh+/off  
B) Fold change of genes in Lshoff/off relative to Lsh+/off plotted against expression in Lsh+/off and colour 
coded to expression in Lshoff/off. There is a tendency in low expression genes in Lsh+/off to be more 
overexpressed in Lshoff/off than the reverse comparison, although the colour coding reveals, despite 
high fold changes the contribution of their genes do not represent a large number of transcripts in 
Lshoff/off optic nerve, 
C) Sum of normalised read counts mapping to IAP elements across libraries sequenced. 
D) qPCR using IAP element specific primers on cDNA from CNS tissues in Lsh+/off and Lshoff/off. Error 









6.2 There is genome wide DNA hypomethylation in Lshoff/off 
OPCs, but these patterns are largely unchanged on 
rescue of LSH expression 
6.2.1 Introduction 
The RNA-seq on P90 optic nerve identifies several potentially causal factors for the OL 
differentiation defect, the failure to upregulate genes involved in cholesterol biosynthesis 
and the overexpression of genes that are non-CNS lineage specific along with 
endogenous transposable elements and genes involved in translation. It is possible that 
any or all of these changes in gene expression are not causal, but either a secondary 
effect of inability to differentiate, in the case of cholesterol biosynthesis genes, or do not 
affect OLs ability to differentiate, which may be the case with the relatively low total 
expression levels of IAPs and non-CNS specific genes.  
To shed light on what aspect of LSH’s molecular function is required for its essential role 
in OL differentiation, I need to distinguish which of these observed changes in 
expression are causal of the OL differentiation defect. In order to attempt this, I need to 
interrogate a system in which the secondary effects of a failure to differentiate, such as 
potentially the lack of late stage gene upregulation, are not apparent, but where the 
molecular cause of failure to differentiate has already been established. Previous 
experiments exploiting the conditionally reversable nature of the Lshoff allele reveal that 
LSH expression in OPCs and late in the lineage can rescue the OL differentiation defect 
(Fig 5.3). In addition, OPC specific knock-out of LSH causes no myelination or OL 
differentiation phenotype. I reasoned therefor that the molecular cause of the Lshoff/off 
phenotype must be present in Lshoff/off OPCs before they differentiate to mOLs. I also 
reasoned if I could interrogate OPCs that have not yet initiated differentiation in Lshoff/off 
and control genotypes, then any secondary effects of a failure to differentiate will not 
have arisen.  
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To address if changes in gene expression revealed in the RNA-seq are compatible with 
OL differentiation, especially conceivable in the case of non-CNS genes and IAPs, I 
needed to interrogate a system in which only a subset of the LSH’s ac tivity was 
recapitulated, but OLs could still differentiate. This would enable me to rule out non-
essential aspects of LSH’s molecular function, as presumably non-essential molecular 
differences from control genotypes seen in Lshoff/off animals would still be present in the 
partial LSH rescue. I reasoned that because Lshoff/off;Pdgfrα-Cre animals still possess 
some phenotypes of Lshoff/off, their progenitors of OPCs lack LSH throughout early 
development before the specification of  OL lineage cells and their OPCs are still 
ultimately able to differentiate and form myelin, they might fit the criteria needed. 
Whether they do depends on if the Lshoff/off;Pdgfrα-Cre OPCs completely rescue all 
molecular defects seen in Lshoff/off, even those not essential for differentiation, but this 
itself could not be seen without some interrogation of their molecular phenotype.  
In addition to which cells to interrogate, I also needed to decide what aspect of LSH’s 
known molecular function to investigate. I hypothesised that as changes in DNA 
methylation are observable in every hypomorphic or Lsh knock-out line and the 
modification recently has been implicated in OL differentiation, though using an approach 
that makes identification of loci requiring methylation for OPCs to dif ferentiate difficult 
(Moyon et al. 2016), that changes in DNA methylation as specific loci in Lshoff/off OPCs 
prior to differentiation were responsible for the differentiation defect . 
6.2.2 Lshoff/off;Pdgfrα-Cre OPCs have only a slight rescue in total mCpG levels, which 
is evenly distributed across genomic features 
To test the hypothesis that rescue in phenotype is accompanied by rescue in DNA 
methylation at regulatory regions of specific genes, I performed whole-genome bisulphite 
sequencing of DNA from OPCs isolated from Lsh+/off;Pdgfra-Cre, Lshoff/off;Pdgfrα-Cre and 
Lshoff/off   P7 cortexes. Fold coverage averaged ~6 across CpGs in libraries for each 
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condition, however ~58% of CpGs were covered by <3 reads, with some regions being 
covered far more than others. I decided to use low coverage initially due to cost constraints, 
and the conceivable possibility that DNA methylation is not restored in the rescued OPCs, as 
previous experiments in the Stancheva lab showed this was the case for LSH regulated loci 
in in vitro rescued MEF cell lines (work by Natalia Torrea). Comparison of total methyl CpG 
levels between genotypes revealed that indeed methylation was not restored in rescued 
OPCs to a significantly above that of Lshoff/off (Fig. 6.7A). I reasoned that it was conceivable 
that differences in the distribution of methylation in the genome could still be an important 
molecular signature for differentiation essential LSH activity. To test this possibility, I decided 
to map percent changes in CpG methylation in 1 Kb windows across genotypes reasoning 
that skewed rescue of methylation in Lshoff/off;Pdgfrα-Cre  to a particular features supports a 
functional impact related to the generalised function of methylation at that feature. For 
example, DNA methylation in promoters is negatively correlated with gene expression 
(Discussed in chapter 1). This analysis revealed no more apparent rescue of CpG 
methylation in any region based on median percentage CpG methylation (Fig. 6.7B). This 
analysis therefore rules out a generalised rescue at methylation in promoters or gene body 
regions, where correlation between gene expression and DNA methylation is more well 
studied. The median value in such the window analysis is heavily skewed by low coverage 
regions giving a binary output for methylation percentage. Coverage however is grossly 
similar across features between genotypes, presumably limiting the effect of this skew in 
comparative analysis (Fig.6.7C), low coverage in certain regions, for example distal 
intergenic, could be an explanation for lack of changes detected in rescue in Lshoff/off;Pdgfrα-
Cre. Due to a lack of statistical significance testing in this analysis, average CpG methylation 
changes at a locus cannot be determined to be greater than those expected by chance. This 
leads to an inability to detect changes at specific features that may have a disproportionate 
impact on the OL differentiation phenotype. There is also no way of telling from this analysis 








6.2.3 Differentially methylated regions overlap extensively between Lshoff/off and 
rescue. 
To try and address these caveats, I decided to see if a skew towards a feature was present 
in statistically significant differentially methylated regions (DMRs) derived from pair-wise 
comparisons between genotypes. Analysis reveals 8107 DMRs in comparison Lshoff/off vs 
Lsh+/off;Pdgfrα-Cre, 7643 in Lshoff/off;Pdgfrα-Cre vs Lsh+/off;Pdgfrα-Cre and 1688 in Lshoff/off vs 
Lshoff/off;Pdgfrα-Cre (Fig.6.8A). The similar number of DMRs in Lshoff/off vs Lsh+/off;Pdgfrα-Cre 
and Lshoff/off;Pdgfrα-Cre vs Lsh+/off;Pdgfrα-Cre supports the conclusion of previous analysis 
that the 2 conditions where LSH has been absent during the early stage of development, 
when most DNA methylation is established (Reik 2007), are comparably different from 
Lsh+/off;Pdgfrα-Cre. Comparison of the genomic feature annotation for these comparisons 
interestingly shows that the largest single feature represent in the DMRs between Lshoff/off vs 
Lsh+/off;Pdgfrα-Cre fall within <=1Kb of a promotor region (Fig.6.8B). This is surprising as 
LSH has previously been characterised to have most impact in regions of heterochromatin. 
This promoter overrepresentation is also present in the Lshoff/off;Pdgfrα-Cre vs Lsh+/off;Pdgfrα-
Cre DMRs, which share a similar distribution in DMR features to Lshoff/off vs Lsh+/off;Pdgfrα-
Cre, though with a lower proportion of promoters differentially methylated in favour for more 
DMRs in distal intergenic regions  (Fig. 6.8C). This proportion of distal intergenic regions 
represented in DMRs is highest in the Lshoff/off vs Lshoff/off;Pdgfrα-Cre DMR feature analysis 
(Fig. 6.8D).  
Figure 6-7 DNA methylation levels are largely unchanged on rescue of LSH expression in the 
oligodendrocyte lineage 
A) Percentage CpG methylation detected in bisulphite sequencing of libraries across genotypes. Error 
bars represent standard deviation between the percentage values given, unpaired t-tests were used 
to calculate statistical significance. *=P<0.05. ***=P<0.0005 
B) Violin plots of percentage methylation for 1kb windows of the genome stratified by contents of 
genomic features. 
C) The same data as B plotted as boxplots with points colour coded according to coverage, with each 
point representing a 1kb window and 1 relative coverage being the most covered window in the 





Despite the Lshoff/off vs Lshoff/off;Pdgfrα-Cre comparison revealing by far the least number of 
DMRs, this was still more than the overall CpG methylation levels in the genotype would 
suggest. This implies that methylation is going both up and down in the DMRs, with the 
average total CpG methylation remaining similar. To gain insight into what extent these 
DMRs represent a return to Lsh+/off;Pdgfrα-Cre DNA methylation patterns, and if those 
returns in methylation could be present in regulatory regions of genes that are conceivably 
related to the OL differentiation phenotype I set out to analyse the overlaps between DMRs 
in  the different comparisons. As expected, the greatest overlap between comparisons is 
between Lshoff/off vs Lsh+/off;Pdgfrα-Cre and Lshoff/off;Pdgfrα-Cre vs Lsh+/off;Pdgfrα-Cre with 
5652 regions  overlapping (Fig. 6.8E). These follow a similar feature distribution to the 
previous comparisons of Lshoff/off or Lshoff/off;Pdgfrα-Cre to Lsh+/off;Pdgfrα-Cre but with an 
increased proportion of promoters represented, supporting the conclusions earlier that these 
are the regions LSH acts on following rescue (Fig. 6.8F). The second biggest overlap is 
between all 3 comparisons, representing 1651, 98% of all DMRs present between Lshoff/off vs 
Lshoff/off;Pdgfrα-Cre,  meaning that nearly all of the DMRs between Lshoff/off vs Lshoff/off;Pdgfrα-
Cre are also present in  Lshoff/off;Pdgfrα-Cre vs Lsh+/off;Pdgfrα-Cre, and so do not represent a 
return to usual patterns required for OL differentiation (Fig.6.8E). Strikingly only 7 DMRs fit 
this criteria, being different between both Lshoff/off vs Lsh+/off;Pdgfrα-Cre and Lshoff/off vs 
Lshoff/off;Pdgfrα-Cre (Fig.6.8E). Only 1 of these is present in the of promoter region of a 
protein coding gene, and 1 a microRNA. Remaining DMRs are equally distributed between 
remaining features (Fig.6.8G). Taken together the bisulphite analysis rejects the hypothesis 
that DNA methylation in OPCs is the causal factor in the Lshoff/off differentiation defect. 
  
Figure 6-8 DMR analysis supports a lack of change in DNA methylation in rescued OPCs 
A) The number of DMRs called across pairwise comparisons between genotypes.                                  
B-D) Distribution of genomic features within DMRs called for pairwise comparisons between genotypes. 
E) Bar graph showing the extent of shared DMRs between different comparisons, a filled in black dot for 
a comparison indicates the bar above includes all the DMRs that are shared with other black dot 
comparisons in the column, and not within any of the unfilled dots.                                                           
F-G) Distribution of genomic features within DMRs called as shared and unique between multiple 









Differential expression analysis of Lshoff/off and Lsh+/off optic nerve RNA-seq and comparison 
to the Barres database reveals that the differentiation defect in Lshoff/off mainly results in a 
under expression of mOL genes, with other CNS cell types at least not being effected in a 
way that alters their differentiation from progenitors or cell fate choice in the optic nerve (as 
would be indicated by a large under-expression or overexpression in genes particular to that 
cell type). Comparison to gene sets defined as changing during OL differentiation highlights 
that the under-expression of mature genes is not generic to all such genes, with some genes 
upregulated late during differentiation being overexpressed in Lshoff/off. The comparison to in 
vivo single cell RNA-seq derived definitions of OL cell types supports both these 
conclusions, with mature genes again being under-expressed but not genes expressed in 
myelin forming OLs or a selection of OL subtypes. However, it cannot be ruled out that this is 
the result of those subtypes not being present in either genotype as they represent a 
character of OL from a different anatomical location or developmental timepoint.  
Gene ontology analysis reveals a strong enrichment for cholesterol biosynthesis genes 
being under expressed in Lshoff/off which could conceivably be a route cause for failure to 
differentiate. However, this could be a secondary effect on expression caused by failure to 
differentiate, rather than mis-regulation of gene expression due to LSH need to be ruled out.  
Attempts to do this by looking at one aspect of chromatin state (DNA methylation) in OPCs, 
a stage we know there is likely to be a defect caused by LSH deficiency, due to the ability of 
cells that lose LSH past this point to differentiate normally, failed to find any significant 
differences between cells unable to differentiate and those that are phenotypically rescued. 
This indicates that some other aspect of LSH function could be responsible for establishing a 
failure to differentiate in OPCs early in life. 
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7. Chapter Seven- Discussion 
Many unanswered questions remain about LSH’s potential function in OL differentiation and 
during this PhD I have only really been successful in characterising that a cell autonomous 
defect in differentiation exists when LSH is absent in OPCs. I will briefly discuss here the 
progress on achieving my project aims, with a view to what future work might be fruitful in 
expanding upon what I have been able to achieve in my PhD. 
7.1 Is Lshoff/off a complete knock-out of LSH expression? 
What phenotypic defect(s) is/are present in the Lshoff/off 
mouse? 
In relation to the first aspect of the aim, I have been successful in quantifying at least a 97% 
knock out in LSH protein through a western blotting approach. However, there are several 
caveats in using this technique to measure extent of knock-out. For example, the less 
efficient transfer of higher molecular weight proteins means it is possible that a fusion protein 
of LSHGFPneo (around 170kDa) exists in these cells, and the difficulty in detecting either 
GFP or LSH via techniques such as immunofluorescence has frustrated attempts to 
overcome this problem. Previously in the Stancheva lab, a mass spectroscopy-based 
attempt of quantifying LSH peptides between Lsh+/+ and Lshoff/off was attempted, but 
insufficient peptide numbers in Lsh+/+ cells made any quantitative comparison impossible. In 
the light of this I think it’s practical to adopt an approach that recognises the possibility of 
hypomorphic mutation in the Lshoff/off allele. So what I have chosen to focus on during my 
project is the phenotype of the Lshoff/off mice.  
Through extensive characterisation of myelination and OPC gene marker expression I have 
successfully characterised a cell autonomous OL differentiation defect, uncovering a new 
role for LSH in this lineage. But this is not the only potentially interesting phenotype these 
mice possess. Small spleen and preliminary data from a previous post-doc Anuj Sengal also 
126 
 
hint at a B-cell maturation defect in these mice. A potential function of LSH in immune cells 
has long been recognised (Geiman and Muegge 2000). This also provides a link with the 
pathophysiology of ICF syndrome, which is recognised to be caused by mutations in Lsh 
(Thijssen et al. 2016). Indeed, several ICF patients have present with corpus callosum 
hypoplasia (Hagleitner et al. 2008)which could conceivably be linked to an as yet 
unrecognised myelination defect. The extent to which this mouse could be used as a 
disease model for therefor ICF warrants further investigation. 
7.2 In what cell type(s) and at what stage in development is 
LSH required? 
Again, progress has been made on this aim through the Pdgfrα-Cre driver experiments 
showing that LSH is specifically required in OPCs and not later in development. A problem 
however is again verifying that the second conversion necessary to convert to Lshoff2 in the 
OPC specific knock-out actually abolishes expression of the protein. Due to LSH’s relatively 
low level of expression and difficulty of detection, an experiment in a cell type that expresses 
LSH highly is required, such as Lshon/on MEFs or ESCs with an inducible Cre. 
Another important question however is can restoration of LSH in adult Lshoff/off CNS rescue 
the phenotype. This experiment is currently in progress using a tamoxifen inducible Cre line 
crossed into Lshoff. Interesting preliminary observations indicate that although the growth and 
weightless phenotype is largely rescued in these animals, they are still ataxic. If it is the case 
that this ataxia is due to inability of OPCs to differentiate even when LSH expression is 
restored, it strongly supports the conclusions of this thesis that early life expression of LSH is 
the essential aspect. If this is the case Lshoff/off could provide a good system in which to study 
the early life chromatin events that are essential for subsequent differentiation. 
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7.3 What is the molecular mechanism of any Lshoff/off 
phenotype? 
This is probably the most unexplored aim of the thesis, despite extensive focus placed on it. 
The result that DNA methylation is not rescued in OPCs rescued for LSH expression 
prompts several possibilities. Does DNA methylation become restored later in life closer to 
differentiation? Is chromatin state at all altered in Lshoff/off OPCs? To address these a more 
thorough exploration of the OPC phenotype is required.  
For example, RNA-seq in OPCs would reveal the loci that become affected before 
secondary effects of failure to differentiate arise, a key caveat of the optic nerve RNA-seq 
experiment. Low in-put ChIP methods are now available that would enable interrogation of 
LSH or histone modifications, such as H3K9me2 and H3K9me3, to see if LSH’s previously 
characterised association with G9a is the crucial effector on chromatin that is important for 
OL differentiation (Brind'Amour et al. 2015). 
A simple experiment that would support the possibility raised by optic nerve RNA-seq that 
cholesterol biosynthesis is the key factor in the Lshoff/off OPC phenotype would be isolation 
and culture of Lshoff/off OPCs supplemented with increased cholesterol or statins, this has 
proven successful in other mouse models deficient in this pathway (Lin et al. 2017). 
An intriguing possibility is that LSH does not act on any particular gene that is important for 
the myelination process, but instead the depletion of heterochromatin caused by its knock-
out leads to a deficit of activating histone modifications and or trans activations of 
transcription. Evidence for this could be the spurious overexpression of normally silent genes 
we see in Lshoff/off optic nerve. With seemingly litter changed in DNA methylation in the 
rescue, it could be that later in development LSH has a DNA methylation independent 
silencing function that can rescue this phenotype. To investigate this a technique such as 
ATAC-seq that interrogates accessibility of chromatin rather than a particular mark. 
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7.4 Final summary 
I have been able to make progress in all aims in this project, uncovering a new role for LSH 
in a postnatal in vivo developmental process and showing that LSH is required early in OPC 
differentiation to mOLs, but not late. Efforts to look into potential mechanisms reveal that 
rescue in phenotype is not accompanied by rescue of DNA methylation early in the lineage, 
opening the possibility that there are previously unknown waves of establishment for de 
novo DNA methylation later in OL lineage, or that LSH in fact possesses DNA-methylation 





8.1 Video 1 
This is an example of a mild ataxia and tremor phenotype in a P80 Lshoff/off animal (top of 
cage on start) and a healthy Lsh+/of littermate. 
8.2 Video 2 
This is an example of a mild ataxia phenotype in a P94 Lshoff/off animal (top of cage at start) 
and 2 healthy Lsh+/off littermates.  
8.3 Video 3 
This is an example of a moderate ataxia and tremor phenotype in an P91 Lshoff/off animal 
(middle of the 3 at start) and 2 healthy Lsh+/off littermates, Increased huntching of back and 
reduced movement are the main contributors to higher score than video 1 or 2. 
8.4 Video 4 
This is an example of severe ataxia and tremor in a P100 Lshoff/off animal. 
8.5 Video 5 
This is a healthy P72 Lshoff/off;Pdgfrα-Cre animal. 
8.6 Video 6 
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